Lumentum Holdings Inc. - Quarter Report: 2020 March (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 28, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission File Number 001-36861

Lumentum Holdings Inc.

(Exact name of Registrant as specified in its charter)



Delaware		47-3108385
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

1001 Ridder Park Drive, San Jose, California 95131

(Address of principal executive offices including Zip code)

(408) 546-5483

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value of $0.001 per share	LITE	Nasdaq Global Select Market

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	x	Accelerated filer	o	Non-accelerated filer	o	Smaller reporting company	☐
						Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

As of April 27, 2020, the Registrant had 74.9 million shares of common stock outstanding.



TABLE OF CONTENTS
			Page
PART I - FINANCIAL INFORMATION
	Item 1.	Financial Statements (Unaudited)
		Condensed Consolidated Statements of Operations for the Three Months and Nine Months Ended March 28, 2020 and March 30, 2019	2
		Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months and Nine Months Ended March 28, 2020 and March 30, 2019	3
		Condensed Consolidated Balance Sheets as of March 28, 2020 and June 29, 2019	4
		Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity for the Three Months and Nine Months Ended March 28, 2020 and March 30, 2019	5
		Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 28, 2020 and March 30, 2019	7
		Notes to Condensed Consolidated Financial Statements	9
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	40
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	53
	Item 4.	Controls and Procedures	55

PART II - OTHER INFORMATION
	Item 1.	Legal Proceedings	56
	Item 1A.	Risk Factors	57
	Item 6.	Exhibits	73

SIGNATURES			74

PART I - FINANCIAL INFORMATION

Item1. Financial Statements (Unaudited)

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

(Unaudited)



	Three Months Ended						Nine Months Ended
	March 28, 2020			March 30, 2019			March 28, 2020			March 30, 2019
Net revenue	$	402.8		$	432.9		$	1,310.5		$	1,160.7
Cost of sales	231.2			316.5			757.2			788.3
Amortization of acquired developed intangibles	13.9			28.1			38.8			33.3
Gross profit	157.7			88.3			514.5			339.1
Operating expenses:
Research and development	48.7			57.7			149.6			135.1
Selling, general and administrative	61.3			55.2			180.4			150.9
Restructuring and related charges	2.7			21.1			4.9			30.2
Impairment charges	2.5			30.7			2.5			30.7
Total operating expenses	115.2			164.7			337.4			346.9
Income (loss) from operations	42.5			(76.4		)	177.1			(7.8		)
Unrealized gain on derivative liability	—			—			—			8.8
Interest expense	(15.6		)	(11.3		)	(45.3		)	(24.9		)
Other income (expense), net	21.7			5.2			27.9			11.7
Income (loss) before income taxes	48.6			(82.5		)	159.7			(12.2		)
Provision for (benefit from) income taxes	5.2			(8.2		)	19.6			(1.6		)
Net income (loss)	$	43.4		$	(74.3	)	$	140.1		$	(10.6	)

Items reconciling net income to net income attributable to common stockholders:
Less: Cumulative dividends on Series A Preferred Stock	—			—			—			(0.3		)
Less: Earnings allocated to Series A Preferred Stock	—			—			—			(1.2		)
Net income (loss) attributable to common stockholders - Basic	$	43.4		$	(74.3	)	$	140.1		$	(12.1	)
Net income (loss) attributable to common stockholders - Diluted	$	43.4		$	(74.3	)	$	140.1		$	(12.1	)

Net income (loss) per share attributable to common stockholders:
Basic	$	0.58		$	(0.98	)	$	1.84		$	(0.18	)
Diluted	$	0.56		$	(0.98	)	$	1.80		$	(0.18	)

Shares used to compute net income (loss) per share attributable to common stockholders:
Basic	74.8			76.2			76.2			68.7
Diluted	77.5			76.2			77.7			68.7

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

(Unaudited)



	Three Months Ended						Nine Months Ended
	March 28, 2020			March 30, 2019			March 28, 2020			March 30, 2019
Net income (loss)	$	43.4		$	(74.3	)	$	140.1		$	(10.6	)
Other comprehensive income (loss), net of tax:
Net change in cumulative translation adjustment	—			—			—			(0.6		)
Net change in unrealized gain (loss) on available-for-sale securities	(1.2		)	1.3			(1.3		)	1.8
Net change in defined benefit obligations	—			—			—			(0.1		)
Other comprehensive income (loss), net of tax	(1.2		)	1.3			(1.3		)	1.1
Comprehensive income (loss), net of tax	$	42.2		$	(73.0	)	$	138.8		$	(9.5	)

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

(Unaudited)



	March 28, 2020		June 29, 2019
ASSETS
Current assets:
Cash and cash equivalents	$	688.3	$	432.6
Short-term investments	763.1		335.9
Accounts receivable, net	261.8		238.0
Inventories	172.7		228.8
Prepayments and other current assets	77.1		97.5
Total current assets	1,963.0		1,332.8
Property, plant and equipment, net	410.1		433.3
Operating lease right-of-use assets, net	81.7		—
Goodwill	368.9		368.9
Other intangible assets, net	338.0		395.4
Deferred income taxes	102.7		169.6
Other non-current assets	4.3		16.6
Total assets	$	3,268.7	$	2,716.6
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	144.6	$	160.8
Accrued payroll and related expenses	50.9		42.3
Accrued expenses	32.9		46.7
Term loan, current	—		5.0
Operating lease liabilities, current	11.5		—
Other current liabilities	46.8		39.2
Total current liabilities	286.7		294.0
Convertible notes	1,106.0		351.9
Term loan, non-current	—		484.0
Operating lease liabilities, non-current	59.1		—
Deferred tax liability	49.0		55.9
Other non-current liabilities	33.7		33.7
Total liabilities	1,534.5		1,219.5
Commitments and contingencies (Note 17)
Stockholders’ equity:
Common stock, $0.001 par value, 990,000,000 authorized shares, 74,874,176 and 76,653,478 shares issued and outstanding as of March 28, 2020 and June 29, 2019, respectively	0.1		0.1
Additional paid-in capital	1,659.1		1,360.8
Retained earnings	69.2		129.1
Accumulated other comprehensive income	5.8		7.1
Total stockholders’ equity	1,734.2		1,497.1
Total liabilities and stockholders’ equity	$	3,268.7	$	2,716.6

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

(in millions)

(Unaudited)



	Common Stock				Additional Paid-In Capital						Accumulated Other Comprehensive Income (Loss)			Total Stockholders' Equity
	Shares		Amount		Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Stockholders' Equity
Balance as of June 29, 2019	76.7		$	0.1	$	1,360.8		$	129.1		$	7.1		$	1,497.1
Net income	—		—		—			47.6			—			47.6
Other comprehensive income	—		—		—			—			0.1			0.1
Issuance of shares pursuant to equity plans, net of tax withholdings	0.5		—		—			—			—			—
Stock-based compensation	—		—		16.5			—			—			16.5
Balance as of September 28, 2019	77.2		$	0.1	$	1,377.3		$	176.7		$	7.2		$	1,561.3
Net income	—		—		—			49.1			—			49.1
Other comprehensive loss	—		—		—			—			(0.2		)	(0.2		)
Issuance of shares pursuant to equity plans, net of tax withholdings	0.3		—		—			—			—			—
Exercise of stock options	—		—		0.3			—			—			0.3
Equity component of the 2026 Notes, net of tax of $67.0 million and issuance costs of $2.3 million	—		—		245.9			—			—			245.9
ESPP shares issued	0.1		—		4.9			—			—			4.9
Repurchases of common stock	(2.9	)	—		—			(200.0		)	—			(200.0		)
Stock-based compensation	—		—		20.3			—			—			20.3
Balance as of December 28, 2019	74.7		$	0.1	$	1,648.7		$	25.8		$	7.0		$	1,681.6
Net income	—		—		—			43.4			—			43.4
Other comprehensive loss	—		—		—			—			(1.2		)	(1.2		)
Issuance of shares pursuant to equity plans, net of tax withholdings	0.2		—		(8.6		)	—			—			(8.6		)
Exercise of stock options	—		—		0.2			—			—			0.2
Stock-based compensation	—		—		18.8			—			—			18.8
Balance as of March 28, 2020	74.9		$	0.1	$	1,659.1		$	69.2		$	5.8		$	1,734.2

Table of Contents

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

(in millions)

(Unaudited)



	Non-Controlling Interest Redeemable Convertible Series A Preferred Stock
					Common Stock			Additional Paid-In Capital						Accumulated Other Comprehensive Income (Loss)			Total Stockholders' Equity
	Shares	Amount			Shares	Amount		Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Stockholders' Equity
Balance as of June 30, 2018	—	$	35.8		62.8	$	0.1	$	753.2		$	166.4		$	6.4		$	926.1
Net income	—	—			—	—		—			47.4			—			47.4
Other comprehensive income	—	—			—	—		—			—			0.5			0.5
Declared dividend for preferred stock	—	—			—	—		—			(0.2		)	—			(0.2		)
Issuance of shares pursuant to equity plans, net of tax withholdings	—	—			0.5	—		—			—			—			—
Stock-based compensation	—	—			—	—		10.3			—			—			10.3
Cumulative-effect adjustment for adoption of Topic 606	—	—			—	—		—			(0.6		)	—			(0.6		)
Balance as of September 29, 2018	—	$	35.8		63.3	$	0.1	$	763.5		$	213.0		$	6.9		$	983.5
Net income	—	—			—	—		—			16.3			—			16.3
Other comprehensive loss	—	—			—	—		—			—			(0.7		)	(0.7		)
Declared dividend for preferred stock	—	—			—	—		—			(0.1		)	—			(0.1		)
Issuance of shares pursuant to equity plans, net of tax withholdings	—	—			0.2	—		(0.8		)	—			—			(0.8		)
Issuance of shares pursuant to merger agreement, net of tax withholdings	—	—			11.0	—		460.1			—			—			460.1
ESPP shares issued	—	—			0.1	—		4.7			—			—			4.7
Stock-based compensation	—	—			—	—		17.3			—			—			17.3
Conversion of preferred stock to common stock	—	(35.8		)	1.5	—		79.4			—			—			79.4
Balance as of December 29, 2018	—	$	—		76.1	$	0.1	$	1,324.2		$	229.2		$	6.2		$	1,559.7
Net loss	—	—			—	—		—			(74.3		)	—			(74.3		)
Other comprehensive income	—	—			—	—		—			—			1.3			1.3
Issuance of shares pursuant to equity plans, net of tax withholdings	—	—			0.2	—		0.1			—			—			0.1
Stock-based compensation	—	—			—	—		17.1			—			—			17.1
Balance as of March 30, 2019	—	$	—		76.3	$	0.1	$	1,341.4		$	154.9		$	7.5		$	1,503.9

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(Unaudited)



	Nine Months Ended
OPERATING ACTIVITIES:	March 28, 2020			March 30, 2019
Net income (loss)	$	140.1		$	(10.6	)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	87.8			74.7
Stock-based compensation	56.1			46.5
Loss on early extinguishment of debt	8.0			—
Unrealized gain on derivative liability	—			(8.8		)
Gain on sale of product lines	(13.8		)	—
Amortization of acquired intangibles	57.4			37.7
Loss and impairment charges on property, plant and equipment	8.9			30.7
Amortization of debt discount and debt issuance costs	25.3			13.6
Amortization of inventory fair value adjustment in connection with Oclaro acquisition	5.8			15.8
Other non-cash income	(2.7		)	(0.2		)
Changes in operating assets and liabilities:
Accounts receivable	(23.8		)	(37.2		)
Inventories	48.3			14.0
Operating lease right-of-use assets, net	9.6			—
Prepayments and other current and non-currents assets	16.5			(10.6		)
Income taxes, net	13.0			(5.1		)
Accounts payable	(15.3		)	15.7
Accrued payroll and related expenses	8.6			(1.4		)
Operating lease liabilities	(10.4		)	—
Accrued expenses and other current and non-current liabilities	(17.8		)	27.6
Net cash provided by operating activities	401.6			202.4
INVESTING ACTIVITIES:
Payments for acquisition of property, plant and equipment	(64.9		)	(80.5		)
Payment for asset acquisition	(4.0		)	(1.3		)
Payment for Oclaro acquisition, net of cash acquired	—			(619.8		)
Proceeds from sale of product lines	18.9			—
Purchases of short-term investments	(692.8		)	(196.1		)
Proceeds from maturities and sales of short-term investments	264.9			172.4
Net cash used in investing activities	(477.9		)	(725.3		)
FINANCING ACTIVITIES:
Repurchase of common stock	(200.0		)	—
Proceeds from the issuance of 0.50% Convertible Notes due 2026, net of issuance costs	1,042.4			—
Tax payments related to restricted stock	(8.6		)	(2.4		)
Payment of dividends - Series A Preferred Stock	—			(0.7		)
Payment of acquisition related holdback	—			(1.0		)
Proceeds from employee stock plans	4.9			4.7
Proceeds from term loan, net of issuance costs	—			490.8
Principal payments on finance leases	(9.2		)	(6.1		)
Proceeds from the exercise of stock options	0.5			0.1
Repayment of term loan	(497.5		)	(1.3		)
Net cash provided by financing activities	332.5			484.1
Effect of exchange rates on cash and cash equivalents	—			(0.2		)
Increase (decrease) in cash, cash equivalents, and restricted cash	256.2			(39.0		)
Cash and cash equivalents at beginning of period	432.6			397.3
Cash, cash equivalents, and restricted cash at end of period	$	688.8		$	358.3

Table of Contents

LUMENTUM HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(Unaudited)



Reconciliation of cash, cash equivalents, and restricted cash, reported within the condensed consolidated balance sheets to the total amounts reported on the condensed consolidated statements of cash flows:
Cash and cash equivalents	$	688.3	$	358.3
Restricted cash	0.5		—
Total cash, cash equivalents, and restricted cash at end of period	$	688.8	$	358.3

Supplemental disclosure of cash flow information:
Cash paid for taxes	$	6.6	$	3.3
Cash paid for interest	10.7		8.7

Supplemental disclosure of non-cash transactions:
Unpaid property, plant and equipment in accounts payable and accrued expenses	$	11.7	$	26.0
Issuance costs in current liabilities	0.2		—
Right-of-use assets obtained in exchange for new operating lease liabilities	2.2		—
Issuance of common stock upon conversion of Series A Preferred Stock	—		79.4
Net transfer of assets from property plant and equipment to assets held-for-sale	—		31.4
Issuance of common stock and replacement awards in connection with Oclaro acquisition	—		460.1

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of Business

Lumentum (“we,” “us,” “our” or the “Company”) is an industry-leading provider of optical and photonic products defined by revenue and market share addressing a range of end market applications including Optical Communications (“OpComms”) and Lasers for manufacturing, inspection and life-science applications. We seek to use our core optical and photonic technology and our volume manufacturing capability to expand into attractive emerging markets that benefit from advantages that optical or photonics based solutions provide, including 3D sensing for consumer electronics and diode light sources for a variety of consumer and industrial applications. The majority of our customers tend to be Original Equipment Manufacturers (“OEMs”) that incorporate our products into their products which then address end-market applications. For example, we sell fiber optic components that Network Equipment Manufacturers’ (“NEMs”) customers assemble into communications networking systems, which they sell to network service providers or enterprises with their own networks. Similarly, many of our customers for our Lasers products incorporate our products into tools they produce, which are used for manufacturing processes by their customers. For 3D sensing, we sell diode lasers to manufacturers of consumer electronics products for mobile, personal computing, gaming, and other applications who then integrate our devices within their products, for eventual resale to consumers and also into other industrial applications. Further, we have begun shipping prototype units of diode lasers and optical subassemblies containing diode lasers and other optical devices to automotive customers for sensing and LiDAR applications.

Basis of Presentation

The preparation of the condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are inventory valuation, revenue recognition, income taxes, long-lived asset valuation, business combinations and goodwill.

On December 10, 2018, we completed our merger with Oclaro, Inc. (“Oclaro”), a provider of optical components and modules for the long-haul, metro and data center markets. Our condensed consolidated financial statements include the operating results of Oclaro beginning from the date of acquisition. Refer to “Note 4. Business Combinations” for further discussion of the merger.

The COVID-19 pandemic has created and may continue to create significant uncertainty in global financial markets, which has disrupted and harmed, and may continue to disrupt and harm, the Company's business, financial condition, and results of operations. The extent of the impact of COVID-19 on the Company's operational and financial performance will depend on certain developments, including but not limited to the duration and spread of the outbreak, duration of local, state and federal issued public health orders in each jurisdiction where we operate or in which our customers and suppliers operate, impact on our customers and our sales cycles, impact on our supply chain and manufacturing partners, impact on our employees and impact on regional and worldwide economies and financial markets in general, all of which are uncertain and cannot be predicted.

Fiscal Years

We utilize a 52-53 week fiscal year ending on the Saturday closest to June 30th. Every fifth or sixth fiscal year will have a 53-week period. The additional week in a 53-week year is added to the third quarter, making such quarter consist of 14 weeks. Our fiscal 2021 will be a 53-week year. Our fiscal 2020 is a 52-week year ending on June 27, 2020, with the quarter ended March 28, 2020 being a 13-week quarterly period. Our fiscal 2019 was a 52-week year that ended on June 29, 2019, with the quarter ended March 30, 2019 being a 13-week quarterly period.

Principles of Consolidation

These interim unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

Certain prior period amounts have been reclassified to conform to the current period presentation, including the reclassification of capital lease obligations that existed as of June 29, 2019 to finance lease liabilities within other current liabilities and other non-current liabilities in our condensed consolidated balance sheets, as a result of the adoption of the new accounting guidance for leases. Refer to “Note 2. Recently Issued Accounting Pronouncements” for details. The reclassification of the prior period amounts did not impact previously reported condensed consolidated financial statements.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Accounting Policies

The accompanying condensed consolidated financial statements and accompanying related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019.

Except for the accounting policies for lease accounting as a result of the adoption of Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), there have been no significant changes to our significant accounting policies as of and for the three months ended March 28, 2020, as compared to the significant accounting policies described in our Annual Report on Form 10-K for the year ended June 29, 2019.

Adoption of Leases (Topic 842)

On June 30, 2019, the first day of fiscal year 2020, we adopted Topic 842, using the modified retrospective transition approach. Refer to “Note 2. Recently Issued Accounting Pronouncements” regarding the impact of adoption.

We determine if an arrangement is a lease at inception for arrangements with an initial term of more than 12 months, and classify it as either finance or operating.

Finance leases are generally those that allow us to substantially utilize or pay for the entire asset over its estimated useful life. Finance leases are recorded in property, plant and equipment, net, and finance lease liabilities within other current and other non-current liabilities on our condensed consolidated balance sheets. We have lease arrangements with lease and non-lease components, and the non-lease components for our finance leases are accounted for separately, based on estimated stand-alone values, and are not included in the initial measurement of our finance lease assets and corresponding liabilities. Finance lease assets are amortized in operating expenses on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease term, with the interest component included in interest expense and recognized using the effective interest method over the lease term.

Operating leases are recorded in operating lease right-of-use assets, net, and operating lease liabilities, current and non-current on our condensed consolidated balance sheets. For operating leases of buildings, we account for non-lease components, such as common area maintenance, as a component of the lease, and include it in the initial measurement of our operating lease assets and corresponding liabilities. Operating lease assets are amortized on a straight-line basis in operating expenses over the lease term.

Our lease liabilities are recognized based on the present value of the remaining fixed lease payments, over the lease term, using a discount rate of similarly secured borrowings available to us. For the purpose of lease liability measurement, we consider only payments that are fixed and determinable at the time of commencement. Any variable payments that depend on an index or rate are expensed as incurred. Our lease terms may include options to extend when it is reasonably certain that we will exercise that option. Our lease assets also include any lease payments made and exclude any lease incentives received prior to commencement. Our lease assets are tested for impairment in the same manner as long-lived assets used in operations. We generally recognize sublease income on a straight-line basis over the sublease term.

Note 2. Recently Issued Accounting Pronouncements

Accounting Pronouncements Recently Adopted

Effective June 30, 2019, we adopted Topic 842, using the modified retrospective transition approach. We applied the new guidance to all leases existing as of the date of adoption. Our reported results beginning with the first quarter of fiscal 2020 reflect the application of Topic 842, while prior period amounts have not been adjusted and continue to be reported in accordance with our historical accounting under Topic 840.

We elected the practical expedient package permitted under the transition approach. As such, we did not reassess whether any expired or existing contracts are or contain leases, we did not reassess our historical lease classification, and we did not reassess our initial direct costs for any leases that existed prior to June 30, 2019. We have also elected to combine lease and non-lease components at a portfolio level for our operating leases of buildings and not to report leases with an initial term of 12 months or less on our balance sheet.

As of the date of adoption, we recognized operating lease assets of $91.5 million, with corresponding operating lease liabilities of $81.5 million on the condensed consolidated balance sheets. The difference between the operating lease right-of-use assets and operating lease liabilities primarily represents the existing asset recognized in relation to the favorable terms of an operating lease acquired through a business combination offset by our deferred rent and ASC 420 “cease-use” balances.

All existing leases that were classified as capital leases under Topic 840 are classified as finance leases under the new guidance. As of adoption, we recognized finance lease assets of $12.4 million in property, plant and equipment, net, with corresponding finance lease liabilities of $12.4 million on the condensed consolidated balance sheets. For further information regarding the impact of Topic 842 adoption, see “Note 1. Description of Business and Summary of Significant Accounting Policies” and “Note 9. Leases”.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

In February 2018, FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows companies to reclassify stranded tax effects resulting from the U.S. Tax Cuts and Jobs Act of 2017 (the “Tax Act”), from accumulated other comprehensive income to retained earnings. The guidance also requires certain new disclosures regardless of the election. The amendments in ASU 2018-02 are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. We adopted ASU 2018-02 in the first quarter of fiscal 2020 with no impact to our condensed consolidated financial statements.

In January 2017, FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment. ASU 2017-04 removes the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. A goodwill impairment charge will be the amount by which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The amendments contained in ASU 2017-04 are effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted, which should be applied prospectively. We early adopted ASU 2017-04 in our first quarter of fiscal 2020. The implementation of ASU 2017-04 did not have an impact on our condensed consolidated financial statements.

Accounting Pronouncements Not Yet Effective

In December 2019, FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which is intended to simplify various aspects related to accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and which also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for us at the beginning of fiscal 2022, including interim periods within that reporting period, although early adoption is permitted. We are currently evaluating the impact of ASU 2019-12 on our condensed consolidated financial statements.

In August 2018, FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans. ASU 2018-14 modifies the disclosure requirements for defined benefit pension plans and other post-retirement benefit plans. The new guidance is effective for fiscal years ending after December 15, 2020, with early adoption permitted. ASU 2018-14 should be applied retrospectively to all periods presented and is effective for us in our first quarter of fiscal 2022. We are currently evaluating the impact of ASU 2018-14 on our condensed consolidated financial statements.

In August 2018, FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. ASU 2018-13 requires that certain of the amendments be applied prospectively, while other amendments should be applied retrospectively to all periods presented. ASU 2018-13 is effective for us in our first quarter of fiscal 2021. We are currently evaluating the impact of ASU 2018-13 on our condensed consolidated financial statements and related disclosures.

In August 2018, FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This standard requires capitalization of the implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. Further, the standard also requires the Company to expense the capitalized implementation costs of a hosting arrangement over the term of the hosting arrangement. This standard is effective for us in our first quarter of fiscal 2021. Early adoption is permitted. The adoption of this standard is not expected to have a significant impact on our consolidated financial statements.

In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and a subsequent amendment, ASU 2018-19 (collectively, Topic 326). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 is effective for annual periods beginning after December 15, 2019, including interim periods within those periods, with early adoption permitted. ASU 2016-13 is effective for us in our first quarter of fiscal 2021. We are currently evaluating the impact of our pending adoption of Topic 326 on our condensed consolidated financial statements.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Note 3. Earnings Per Share

The following table sets forth the computation of basic and diluted net income attributable to common stockholders per share (in millions, except per share data):



	Three Months Ended					Nine Months Ended
	March 28, 2020		March 30, 2019			March 28, 2020		March 30, 2019
Basic Earnings per Common Share
Net income (loss)	$	43.4	$	(74.3	)	$	140.1	$	(10.6	)
Less: Cumulative dividends on Series A Preferred Stock	—		—			—		(0.3		)
Less: Earnings allocated to Series A Preferred Stock	—		—			—		(1.2		)
Net income (loss) attributable to common stockholders - Basic	$	43.4	$	(74.3	)	$	140.1	$	(12.1	)

Weighted average common shares outstanding including Series A Preferred Stock	74.8		76.2			76.2		69.4
Less: Weighted average Series A Preferred Stock	—		—			—		(0.7		)
Basic weighted average common shares outstanding	74.8		76.2			76.2		68.7
Net income (loss) per share attributable to common stockholders - Basic	$	0.58	$	(0.98	)	$	1.84	$	(0.18	)

Diluted Earnings per Common Share
Net income (loss) attributable to common stockholders - Basic	$	43.4	$	(74.3	)	$	140.1	$	(12.1	)
Net income (loss) attributable to common stockholders - Diluted	$	43.4	$	(74.3	)	$	140.1	$	(12.1	)

Weighted average common shares outstanding for basic earnings per common share	74.8		76.2			76.2		68.7
Effect of dilutive securities from 2015 Equity Incentive Plan	1.0		—			0.8		—
Shares issuable assuming conversion of the 2024 Notes	1.7		—			0.7		—
Diluted weighted average common shares outstanding	77.5		76.2			77.7		68.7
Net income (loss) per share attributable to common stockholders - Diluted	$	0.56	$	(0.98	)	$	1.80	$	(0.18	)

Our Series A Preferred Stock was considered a participating security, meaning that it had the right to participate in undistributed earnings with our common stock. On November 2, 2018, the remaining 35,805 shares of our Series A Preferred Stock were converted into 1.5 million shares of our common stock. Refer to “Note 11. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability” for further discussion. Prior to conversion, the holders of our Series A Preferred Stock were entitled to share in dividends, on an as-converted basis, if the holders of our common stock were to receive dividends. Through the date of conversion, we used the two-class method to compute earnings per share. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net earnings to allocate to common stockholders, earnings are allocated to both common and participating securities based on their respective weighted-average shares outstanding during the period. Diluted earnings per common share is calculated similar to basic earnings per common share except that it gives effect to all potentially dilutive common stock equivalents outstanding for the period, using the treasury stock method. Diluted earnings per common share is computed using the more dilutive of the treasury stock method or the if-converted method.

Potentially dilutive common shares result from the assumed exercise of outstanding stock options, assumed vesting of outstanding equity awards, assumed issuance of stock under the employee stock purchase plan, and assumed conversion of our outstanding $450 million in aggregate principal amount of 0.25% Convertible Notes due in 2024 (the “2024 Notes”) and $1,050 million in aggregate principal amount of 0.50% Convertible Notes due in 2026 (the “2026 Notes” and together with the 2024 Notes, the “convertible notes”), all using the treasury stock method.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

We have the ability and intent to settle the face value of our convertible notes in cash. Therefore, we use the treasury stock method for calculating the dilutive impact of the convertible notes. The 2026 Notes will have no impact on diluted earnings per share until the average price of our common stock exceeds the conversion price of $99.29. The potentially dilutive shares resulting from the 2024 Notes were included in the calculation of diluted income per share for the three and nine months ended March 28, 2020 since the average price of our common stock exceeded the conversion price of $60.62. Refer to “Note 12. Debt” for further discussion.

Anti-dilutive potential shares from the 2015 Equity Incentive Plan are excluded from the calculation of diluted earnings per share if their exercise price exceeded the average market price during the period or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method. Anti-dilutive shares excluded from the calculation of diluted earnings per share were not material for the three and nine months ended March 28, 2020, respectively. Anti-dilutive shares excluded from the calculation of diluted earnings per share were 0.7 million shares and 0.6 million shares, respectively, for the three and nine months ended March 30, 2019, respectively.

Note 4. Business Combinations

On December 10, 2018, we acquired all of the outstanding common stock of Oclaro, a provider of optical components and modules for the long-haul, metro and data center markets. Oclaro’s products provide differentiated solutions for optical networks and high-speed interconnects driving the next wave of streaming video, cloud computing, application virtualization and other bandwidth-intensive and high-speed applications.

The total fair value of consideration given in connection with the acquisition of Oclaro consisted of the following:



	Shares	Per Share		Total Consideration (in millions)
Cash paid for outstanding Oclaro common stock				$	964.8
Lumentum common shares issued to Oclaro stockholders	10,941,436	$	41.80	457.4
Replacement equity awards for Oclaro equity awards				2.7
Total consideration				$	1,424.9

The total transaction consideration was funded by the issuance of Lumentum common stock, new debt, and cash balances of the combined company.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Our allocation of the purchase price of Oclaro based on the estimated fair values of the assets acquired and liabilities assumed is as follows (in millions):



	As Previously Reported on June 29, 2019
Cash and cash equivalents	$	345.0
Accounts receivable, net	68.0
Inventories	155.0
Prepayments and other current assets	33.7
Property, plant and equipment, net	134.7
Intangibles	444.0
Deferred income tax asset	42.6
Other non-current assets	16.6
Accounts payable	(57.8		)
Accrued payroll and related expenses	(11.4		)
Accrued expenses	(8.3		)
Other current liabilities	(6.1		)
Deferred tax liability	(75.8		)
Other non-current liabilities	(12.9		)
Goodwill	357.6
Total purchase price	$	1,424.9

The amounts presented in the table above pertained to the preliminary purchase price allocation reported in our Form 10-K for the year ended June 29, 2019, filed with the Securities and Exchange Commission on August 27, 2019. There have been no measurement period adjustments during the three and nine months ended March 28, 2020.

On April 18, 2019, we completed the sale of our Datacom transceiver module business based in Sagamihara, Japan and the transfer of related employees to Cambridge Industries Group (“CIG”) for $25.5 million in net cash. These product lines were initially acquired by us through the acquisition of Oclaro. This business did not meet the criteria for assets held-for-sale under the relevant accounting guidance as of December 10, 2018, the date of our acquisition of Oclaro, in our purchase price allocation. The assets and liabilities transferred to CIG were $33.5 million and $7.0 million, respectively.

Supplemental Pro Forma Information

The supplemental pro forma financial information presented below is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the acquisition had been completed on the date indicated, does not reflect synergies that might have been achieved, nor is it indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions we believe are reasonable under the circumstances.

The following supplemental pro forma information presents the combined results of operations for the nine months ended March 30, 2019, as if Oclaro had been acquired as of the beginning of fiscal year 2018. The supplemental pro forma information includes adjustments to amortization and depreciation for acquired intangible assets and property and equipment, adjustments to share-based compensation expense, the fair value adjustments on the inventories acquired, transaction costs, interest expense and amortization of the term loan debt issuance costs.

The unaudited supplemental pro forma financial information for the period presented is as follows (in millions):



	Nine Months Ended
	March 30, 2019

Net revenue	$	1,374.8
Net loss	(18.2		)

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Note 5. Assets and Liabilities Held For Sale

We continually evaluate our existing portfolio of businesses to maximize long-term shareholder value. We consider assets and liabilities as held-for-sale when management approves and commits to a plan to actively market assets or a group of assets for sale. Assets held-for-sale are recorded initially at the lower of its carrying value or its estimated fair value, less estimated costs to sell. Upon designation as an asset held-for-sale, we discontinue recording depreciation expense on such asset.

Lithium Niobate modulators

Following our acquisition of Oclaro, we announced our plan to discontinue development and manufacturing of Lithium Niobate modulators and wind down these operations in our San Donato, Italy site. In the second quarter of fiscal year 2020, we entered into an agreement with Advanced Fiber Resources (Zhuhai) Ltd. ("AFR"), a leading provider of passive optical components, to sell the assets associated with certain Lithium Niobate product lines manufactured by our San Donato site for $17 million. This sale was completed in the third quarter of fiscal year 2020, and we received the final proceeds of $16.9 million, net of $0.1 million retainer from AFR. The assets sold of $6.6 million primarily consisted of property, plant and equipment, net, inventory, and operating lease right-of-use assets, net, offset by liabilities transferred of $3.5 million primarily attributable to operating lease liabilities. During the three months ended March 28, 2020, we recognized a gain of $13.8 million, which was recorded in our other income (expense), net in the condensed consolidated statements of operations. With the close of this transaction, our telecom transmission product strategy is now focused on Indium Phosphide photonic integrated circuits, as well as components and modules that incorporate these Indium Phosphide photonic integrated circuits.

Datacom transceiver modules

As of June 29, 2019, we had $4.9 million of long-lived assets related to our plan to discontinue the development of future Datacom transceiver modules. As these assets were not deemed to be useful, we retired them from active use and classified them as held-for-sale on our balance sheet. This is a result of the strategic change we made in the third quarter of fiscal year 2019 when we announced the exit from the Datacom transceiver modules and investments in the new Datacom chips development. In the third quarter of fiscal year 2020, we sold $2.0 million and impaired $1.6 million of these assets held-for-sale. As of March 28, 2020, the remaining balance of $1.3 million is expected to be sold in the subsequent quarters.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Note 6. Cash, Cash Equivalents and Short-term Investments

The following table summarizes our cash, cash equivalents and short-term investments by category for the periods presented (in millions):



	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 28, 2020:
Cash	$	121.3	$	—	$	—		$	121.3
Cash equivalents:
Commercial paper	72.6		—		—			72.6
Corporate debt securities	3.0		—		—			3.0
Money market funds	426.2		—		—			426.2
U.S. Treasury securities	65.1		0.1		—			65.2
Total cash and cash equivalents	$	688.2	$	0.1	$	—		$	688.3
Short-term investments:
Certificates of deposit	$	4.4	$	—	$	—		$	4.4
Commercial paper	88.1		—		—			88.1
Corporate debt securities	343.2		0.2		(2.5		)	340.9
Foreign government bonds	4.0		—		—			4.0
U.S. Agency securities	23.0		0.1		—			23.1
U.S. Treasury securities	300.7		1.9		—			302.6
Total short-term investments	$	763.4	$	2.2	$	(2.5	)	$	763.1

June 29, 2019:
Cash	$	213.8	$	—	$	—		$	213.8
Cash equivalents:
Commercial paper	37.4		—		—			37.4
Money market funds	168.1		—		—			168.1
U.S. Treasury securities	13.3		—		—			13.3
Total cash and cash equivalents	$	432.6	$	—	$	—		$	432.6
Short-term investments:
Certificates of deposit	$	1.9	$	—	$	—		$	1.9
Commercial paper	22.3		—		—			22.3
Asset-backed securities	54.9		0.2		—			55.1
Corporate debt securities	207.6		0.9		(0.1		)	208.4
Municipal bonds	1.3		—		—			1.3
Mortgage-backed securities	6.6		—		—			6.6
Foreign government bonds	6.2		—		—			6.2
U.S. Agency securities	4.6		—		—			4.6
U.S. Treasury securities	29.4		0.1		—			29.5
Total short-term investments	$	334.8	$	1.2	$	(0.1	)	$	335.9

We use the specific-identification method to determine any realized gains or losses from the sale of our short-term investments classified as available-for-sale. During the three and nine months ended March 28, 2020 and March 30, 2019, we did not realize significant gains or losses on a gross level from the sale of our short-term investments classified as available-for-sale.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

During the three and nine months ended March 28, 2020, our other income (expense), net was $21.7 million and $27.9 million, respectively, and includes interest income on cash equivalents and short-term investments of $5.2 million and $12.6 million, respectively. During the three and nine months ended March 30, 2019, our other income (expense), net was $5.2 million and $11.7 million, respectively, and includes interest income on cash equivalents and short-term investments of $3.9 million and $10.0 million, respectively.

The following table summarizes unrealized losses on our cash equivalents and short-term investments by category and length of time the investment has been in a continuous unrealized loss position as of the periods presented (in millions):



	Less than 12 months					12 Months or Greater					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
March 28, 2020:
U.S. Agency securities	$	8.0	$	—		$	—	$	—		$	8.0	$	—
Certificates of deposit	2.5		—			—		—			2.5		—
Commercial paper	55.2		—			—		—			55.2		—
Corporate debt securities	301.1		(2.5		)	—		—			301.1		(2.5		)
Total	$	366.8	$	(2.5	)	$	—	$	—		$	366.8	$	(2.5	)

June 29, 2019:
Asset-backed securities	$	4.2	$	—		$	5.9	$	—		$	10.1	$	—
Corporate debt securities	9.6		—			35.9		(0.1		)	45.5		(0.1		)
Foreign government bonds	—		—			2.1		—			2.1		—
U.S. government bonds	6.9		—			—		—			6.9		—
Total	$	20.7	$	—		$	43.9	$	(0.1	)	$	64.6	$	(0.1	)

The following table classifies our short-term investments by contractual maturities (in millions):



	March 28, 2020				June 29, 2019
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Due in 1 year	$	720.1	$	720.0	$	178.9	$	179.1
Due in 1 year through 5 years	43.3		43.1		148.1		149.0
Due in 5 years through 10 years	—		—		6.0		6.0
Due after 10 years	—		—		1.8		1.8
	$	763.4	$	763.1	$	334.8	$	335.9

All available-for-sale securities have been classified as current, based on management’s intent and ability to use the funds in current operations.

Note 7. Fair Value Measurements

We determine fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)



Level 1:	Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2:	Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.
Level 3:	Inputs are unobservable inputs based on our assumptions.

The fair value of our Level 1 financial instruments, such as money market funds, which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of our Level 2 fixed income securities is obtained from an independent pricing service, which may use quoted market prices for identical or comparable instruments or model driven valuations using observable market data or inputs corroborated by observable market data. Our marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. Our procedures include controls to ensure that appropriate fair values are recorded, including comparing the fair values obtained from our pricing service against fair values obtained from another independent source.

Based on quoted market prices as of March 28, 2020, the fair values of the 2026 Notes and the 2024 Notes (refer to “Note 12. Debt”) were approximately $1.0 billion and $581.0 million, respectively, determined using Level 2 inputs as they are not actively traded in markets.

Financial assets and liabilities measured at fair value on a recurring basis are summarized below (in millions):



	Level 1		Level 2		Level 3		Total
March 28, 2020: ⁽¹⁾
Assets:
Cash equivalents:
Commercial paper	$	—	$	72.6	$	—	$	72.6
Corporate debt securities	—		3.0		—		3.0
Money market funds	426.2		—		—		426.2
U.S. Treasury securities	65.2		—		—		65.2
Short-term investments:
Certificates of deposit	—		4.4		—		4.4
Commercial paper	—		88.1		—		88.1
Corporate debt securities	—		340.9		—		340.9
Foreign government bonds	—		4.0		—		4.0
U.S. Agency securities	—		23.1		—		23.1
U.S. Treasury securities	302.6		—		—		302.6
Total assets	$	794.0	$	536.1	$	—	$	1,330.1

(1) Excludes $121.3 million in cash held in our bank accounts at March 28, 2020.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)



	Level 1		Level 2		Level 3		Total
June 29, 2019: ⁽¹⁾
Assets:
Cash equivalents:
Commercial paper	$	—	$	37.4	$	—	$	37.4
Money market funds	168.1		—		—		168.1
U.S. Treasury securities	13.3		—		—		13.3
Short-term investments:
Certificates of deposit	—		1.9		—		1.9
Commercial paper	—		22.3		—		22.3
Asset-backed securities	—		55.1		—		55.1
Corporate debt securities	—		208.4		—		208.4
Municipal bonds	—		1.3		—		1.3
Mortgage-backed securities	—		6.6		—		6.6
Foreign government bonds	—		6.2		—		6.2
U.S. Agency securities	—		4.6		—		4.6
U.S. Treasury securities	29.5		—		—		29.5
Total assets	$	210.9	$	343.8	$	—	$	554.7
Other accrued liabilities:
Acquisition contingency	$	—	$	—	$	2.7	$	2.7
Total other accrued liabilities	$	—	$	—	$	2.7	$	2.7

(1) Excludes $213.8 million in cash held in our bank accounts as of June 29, 2019.

Assets Measured at Fair Value on a Non-Recurring Basis

We periodically review our intangible and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated undiscounted cash flows resulting from use of the asset and its eventual disposition. If not recoverable, an impairment loss would be calculated based on the excess of the carrying amount over the fair value.

Management utilizes various valuation methods, including an income approach, a market approach and a cost approach, to estimate the fair value of intangible and other long-lived assets. During the annual impairment testing performed in fiscal 2019, we concluded that our intangible and other long-lived assets were not impaired.

No impairment charges were recorded during the three and nine months ended March 28, 2020 and March 30, 2019. Refer to “Note 10. Goodwill and Other Intangible Assets”.

Note 8. Balance Sheet Details

Accounts receivable allowances

As of March 28, 2020 and June 29, 2019, our accounts receivable allowance balance was $1.7 million and $4.5 million, respectively.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Inventories

The components of inventories were as follows (in millions):



	March 28, 2020		June 29, 2019
Raw materials and purchased parts	$	55.4	$	78.3
Work in process	67.9		72.5
Finished goods	49.4		78.0
Inventories⁽¹⁾	$	172.7	$	228.8

(1) The inventory balance as of June 29, 2019 includes $5.7 million, net of amortization, related to the inventory step-up adjustment from the Oclaro acquisition. As of March 28, 2020, the inventory step-up adjustment from the Oclaro acquisition was fully amortized.

Prepayments and other current assets

The components of prepayments and other current assets were as follows (in millions):



	March 28, 2020		June 29, 2019
Prepayments	$	29.7	$	32.4
Vendor receivable	29.8		36.3
Value added tax receivable	11.5		11.9
Advances to contract manufacturers	—		8.7
Assets held-for-sale	1.3		4.9
Other current assets	4.8		3.3
Prepayments and other current assets	$	77.1	$	97.5

Operating lease right-of-use assets, net

Operating lease right-of-use assets, net were as follows (in millions):



	March 28, 2020
Operating lease right-of-use assets	$	90.3
Less: accumulated amortization	(8.6		)
Operating lease right-of-use assets, net	$	81.7

Property, plant and equipment, net

The components of property, plant and equipment, net were as follows (in millions):



	March 28, 2020			June 29, 2019
Land	$	44.2		$	44.2
Buildings and improvement	112.9			103.7
Machinery and equipment ⁽¹⁾	514.1			500.5
Computer equipment and software	25.6			25.4
Furniture and fixtures	6.6			4.9
Leasehold improvements	28.1			31.2
Finance lease right-of-use assets ⁽¹⁾	28.1			16.0
Construction in progress	53.0			46.8
	812.6			772.7
Less: Accumulated depreciation ⁽¹⁾	(402.5		)	(339.4		)
Property, plant and equipment, net	$	410.1		$	433.3

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

(1) Included in the table above is our equipment acquired under finance leases. As of March 28, 2020 and June 29, 2019, the accumulated depreciation of finance lease right-of-use assets was $24.2 million and $11.2 million, respectively. For fiscal 2019 in accordance with Topic 842, we have reclassified $16.0 million of equipment acquired under finance leases from machinery and equipment to finance lease right-of-use assets to conform to current period presentation.

During the three and nine months ended March 28, 2020, we recorded depreciation expense of $27.5 million and $87.8 million, respectively. During the three and nine months ended March 30, 2019, we recorded depreciation expense of $29.0 million and $74.7 million, respectively.

Included in these amounts were depreciation expense for equipment acquired under finance leases in the amount of $4.8 million and $13.0 million for the three and nine months ended March 28, 2020, respectively, and $1.5 million and $4.6 million for the three and nine months ended March 30, 2019, respectively.

In fiscal 2019, we purchased a property in San Jose, California for $54.6 million in cash. We relocated our corporate headquarters to this new San Jose location in the second quarter of fiscal 2020. The allocations of value were $21.7 million to buildings and improvement and $32.9 million to the land.

Our construction in progress primarily includes machinery and equipment that we expect to place in service in the next 12 months.

Other current liabilities

The components of other current liabilities were as follows (in millions):



	March 28, 2020		June 29, 2019
Restructuring accrual and related charges ⁽¹⁾	$	2.6	$	14.6
Warranty accrual ⁽²⁾	5.4		7.5
Deferred revenue and customer deposits	1.7		2.9
Finance lease liabilities, current ⁽³⁾	3.9		0.4
Income tax payable	30.4		8.7
Other current liabilities	2.8		5.1
Other current liabilities	$	46.8	$	39.2

(1) Refer to “Note 14. Restructuring and Related Charges.”

(2) Refer to “Note 17. Commitments and Contingencies.”

(3) For fiscal 2019 in accordance with Topic 842, we have reclassified amounts from capital lease obligations to finance lease liabilities to conform to current period presentation. In addition to the $3.9 million of finance lease liabilities recorded within other current liabilities as of March 28, 2020, we also recorded $0.1 million within other non-current liabilities in the condensed consolidated balance sheet. Refer to “Note 9. Leases.”

Other non-current liabilities

The components of other non-current liabilities were as follows (in millions):



	March 28, 2020		June 29, 2019
Asset retirement obligations	$	4.9	$	4.5
Pension and related accrual ⁽¹⁾	10.0		7.9
Deferred rent	—		2.2
Unrecognized tax benefit	18.1		18.7
Finance lease liabilities, non-current	0.1		—
Other non-current liabilities	0.6		0.4
Other non-current liabilities	$	33.7	$	33.7

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

(1) We have defined benefit pension plans in Japan, Switzerland, and Thailand. As of March 28, 2020, the projected benefit obligations in Japan, Switzerland, and Thailand were $2.8 million, $4.7 million, and $2.5 million, respectively. As of June 29, 2019, the projected benefit obligations for Japan and Switzerland were $2.8 million and $5.0 million, respectively. Pension and related accruals as of June 29, 2019 also include $0.1 million attributable to post-retirement benefits for executives.

Note 9. Leases

We lease certain real and personal property from unrelated third parties under non-cancellable operating leases that expire at various dates through fiscal 2033. These operating leases are mainly for administrative offices, research-and-development and manufacturing facilities, as well as sales offices in various countries around the world. Certain leases require us to pay property taxes, insurance and routine maintenance, and include escalation clauses. Many leases include one or more options to renew. We do not assume renewals in our determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement.

We have also entered into various finance leases to obtain servers and certain other equipment for our operations. These arrangements are typically for two to four years.

As of March 28, 2020, we sublease certain floors of our offices in the United Kingdom, the United States, Canada, and Japan. These subleases will expire at various dates by fiscal year 2023. We anticipate receiving approximately $5.9 million in sublease income over the next three years.

The components of lease costs, lease term, and discount rate are as follows:

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)



	Three Months Ended			Nine Months Ended
	March 28, 2020			March 28, 2020
Finance lease cost (in millions):
Amortization of right-of-use assets	$	4.8		$	13.0
Interest	—			0.1
Operating lease cost	3.9			11.9
Variable lease cost	0.4			1.5
Short-term lease cost	0.7			1.7
Sublease income	(0.7		)	(1.9		)
Total lease cost	$	9.1		$	26.3

Weighted average remaining lease term (in years):
Operating leases				8.9
Finance leases				0.7
Weighted average discount rate:
Operating leases				3.65		%
Finance leases				4.38		%

As of March 28, 2020, maturities of our operating and finance lease liabilities, which do not include short-term leases and variable lease payments, were as follows (in millions):



Fiscal Years	Operating Leases ⁽¹⁾			Finance Leases		Total
Remainder of 2020	$	3.3		$	3.4	$	6.7
2021	13.1			0.6		13.7
2022	12.3			—		12.3
2023	11.1			—		11.1
2024	9.4			—		9.4
Thereafter	31.4			—		31.4
Total minimum lease payments	$	80.6		$	4.0	$	84.6
Less: amount representing interest	(10.0		)	—		(10.0		)
Present value of total lease liabilities	$	70.6		$	4.0	$	74.6

(1) Non-cancellable sublease proceeds for the remainder of fiscal 2020, and fiscal 2021, 2022, and 2023 of $0.7 million, $2.4 million, $2.2 million, and $0.6 million, respectively, are not included in the table above.

Prior to our adoption of Topic 842, future minimum lease payments as of June 29, 2019, which were undiscounted, were net of our sublease income amounts, and included lease and non-lease components, were as follows (in millions):



Fiscal Years	Operating Leases		Finance Leases		Total
2020	$	13.9	$	0.8	$	14.7
2021	12.1		—		12.1
2022	11.2		—		11.2
2023	11.3		—		11.3
2024	9.8		—		9.8
Thereafter	31.7		—		31.7
Total minimum operating lease payments	$	90.0	$	0.8	$	90.8

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Note 10. Goodwill and Other Intangible Assets

Goodwill

On December 10, 2018, we completed the acquisition of Oclaro. We recognized goodwill in the amount of $357.6 million for the acquisition of Oclaro and allocated it to our OpComms segment. There have been no measurement periods or other adjustments to goodwill during the three and nine months ended March 28, 2020. The following table presents our goodwill balance by the reportable segments as of March 28, 2020 (in millions):



	Optical Communications		Commercial Lasers		Total
Balance as of March 28, 2020	$	363.5	$	5.4	$	368.9

Impairment of Goodwill

We review goodwill for impairment during the fourth quarter of each fiscal year or more frequently if events or circumstances indicate that an impairment loss may have occurred. In the fourth quarter of fiscal 2019, we completed the annual impairment test of goodwill, which indicated there was no goodwill impairment.

We considered the impacts of COVID-19 pandemic on our business and determined that there were no indicators of goodwill impairment as of March 28, 2020.

Other Intangibles

In connection with our acquisition of Oclaro in fiscal year 2019, we recorded $443.0 million as the fair value of the acquired developed technologies and other intangible assets. This amount excludes $1.0 million of in-process research and development assets that were subsequently sold to CIG. Refer to “Note 4. Business Combinations”.

The intangible assets are amortized on a straight-line basis over the estimated useful lives, except for customer relationships and order backlog, which are amortized using an accelerated method of amortization over the expected customer lives, which more accurately reflects the pattern of realization of economic benefits expected to be obtained. Acquired developed technologies and order backlog are amortized to cost of sales and customer relationships is amortized to selling, general and administrative. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When an IPR&D project is completed, the IPR&D is reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life expected to range between 4 to 9 years.

The following tables present details of our other intangibles, including those acquired in connection with the Oclaro acquisition, as of the periods presented (in millions, except for weighted average remaining amortization period):



March 28, 2020	Gross Carrying Amounts		Accumulated Amortization			Net Carrying Amounts		Weighted average remaining amortization period (years)
Acquired developed technologies ⁽¹⁾	$	346.5	$	(161.9	)	$	184.6	3.5
Customer relationships	149.3		(30.9		)	118.4		6.7
In-process research and development ⁽¹⁾	35.0		—			35.0		n/a
Order backlog	22.0		(22.0		)	—		—
Other intangibles	2.7		(2.7		)	—		—
Total intangible assets	$	555.5	$	(217.5	)	$	338.0

(1) During the three and nine months ended March 28, 2020, we completed $7 million and $59 million of IPR&D projects, respectively, and reclassified the value assigned to them to acquired developed technologies. The amount will be amortized over the assets’ estimated useful life of 4 to 5 years.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)



June 29, 2019	Gross Carrying Amounts		Accumulated Amortization			Net Carrying Amounts		Weighted average remaining amortization period (years)
Acquired developed technologies	$	287.5	$	(125.2	)	$	162.3	3.8
Customer relationships	149.3		(12.3		)	137.0		7.5
In-process research and development	94.0		—			94.0		n/a
Order backlog	22.0		(19.9		)	2.1		0.5
Other intangibles	2.7		(2.7		)	—		—
Total intangible assets	$	555.5	$	(160.1	)	$	395.4

The following table presents details of amortization for the periods presented (in millions):



	Three Months Ended				Nine Months Ended
	March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019
Cost of sales	$	13.9	$	28.1	$	38.8	$	33.3
Selling, general and administrative	6.1		3.6		18.6		4.4
Total amortization of intangibles	$	20.0	$	31.7	$	57.4	$	37.7

Based on the carrying amount of our acquired developed technologies and other intangibles, excluding IPR&D, as of March 28, 2020, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):



Fiscal Years
Remainder of 2020	$	20.3
2021	78.9
2022	76.4
2023	52.9
2024	33.1
Thereafter	41.4
Total future amortization	$	303.0

Note 11. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability

On July 31, 2015, our wholly-owned subsidiary, Lumentum Inc., issued 40,000 shares of its Series A Preferred Stock to Viavi Solutions Inc. (“Viavi”). Pursuant to a securities purchase agreement between us, Viavi and Amada Holdings Co., Ltd. (“Amada”), 35,805 shares of Series A Preferred Stock were sold by Viavi to Amada in August 2015. The remaining 4,195 shares of the Series A Preferred Stock were canceled.

As of June 30, 2018, the Series A Preferred Stock was referred to as our Non-Controlling Interest Redeemable Convertible Preferred Stock within these condensed consolidated financial statements, and was recorded at $35.8 million.

On October 15, 2018, we issued a 30-day notice of intent to the holders of Series A Preferred Stock to convert all shares of Series A Preferred Stock at a conversion price equal to the Issuance Value divided by $24.63 plus the accrued and unpaid dividends on each share and any past due dividends, whether or not authorized or declared. On November 2, 2018, we received notice from Amada of their intent to convert the Series A Preferred Stock and we issued 1.5 million shares of our common stock to Amada upon the conversion of the 35,805 shares of Series A Preferred Stock and recorded $79.4 million in additional paid in capital in the condensed consolidated balance sheet.

Through the date of conversion, the Series A Preferred Stock conversion feature was bifurcated from the Series A Preferred Stock and accounted for separately as a derivative liability. The derivative liability was measured at fair value each reporting period, and at the date of conversion, with the change in fair value recorded in the condensed consolidated statements of operations.

Through the date of conversion, holders of Series A Preferred Stock, in preference to holders of common stock or any other class or series of our outstanding capital stock ranking in any such event junior to the Series A Preferred Stock, were entitled to

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

receive, when and as declared by the board of directors, quarterly cumulative cash dividends at the annual rate of 2.5% of the Issuance Value per share on each outstanding share of Series A Preferred Stock. The accrued dividends were payable on March 31, June 30, September 30 and December 31 of each year commencing on September 30, 2015. The accrued dividends as of November 2, 2018, the effective date of the conversion of all outstanding Series A Preferred Stock, was $0.3 million. During the three months ended March 30, 2019, we paid $0.4 million in dividends to the holders of Series A Preferred Stock.

In connection with the conversion of the Series A Preferred Stock on November 2, 2018, we recorded $79.4 million in additional paid in capital which is reflected within the condensed consolidated balance sheets as of March 28, 2020 and June 29, 2019. For the nine months ended March 30, 2019, we recorded $8.8 million unrealized gain to our condensed consolidated statements of operations.

Note 12. Debt

Convertible Notes

2026 Notes

In December 2019, we issued $1,050.0 million in aggregate principal amount of the 2026 Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The 2026 Notes are governed by an indenture between the Company and U.S. Bank National Association (the “2026 Indenture”). We used approximately $196 million of the net proceeds of the offering to repay in full all amounts outstanding under our term loan credit facility, and a portion of the net proceeds of the offering to purchase approximately $200 million of our common stock concurrently with the pricing of the offering in privately negotiated transactions. The 2026 Notes are unsecured and do not contain any financial covenants, restrictions on dividends, incurrence of senior debt or other indebtedness, or the issuance or repurchase of securities by us.

The 2026 Notes will bear interest at a rate of 0.50% per year, payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2020. The 2026 Notes will mature on December 15, 2026, unless earlier redeemed, repurchased by us, or converted pursuant to their terms.

The initial conversion rate is 10.0711 shares of common stock per $1,000 principal amount of the 2026 Notes (which is equivalent to an initial conversion price of approximately $99.29 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events but will not be adjusted for accrued and unpaid interest. In addition, upon the occurrence of a make-whole fundamental change or our issuance of a notice of redemption, we will, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert the 2026 Notes in connection with such make-whole fundamental change or notice of redemption.

Prior to the close of business on the business day immediately preceding September 15, 2026, holders of the 2026 Notes may convert their 2026 Notes only under the following circumstances:

•

during any fiscal quarter commencing after the fiscal quarter ended on March 28, 2020 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price of the 2026 Notes on each applicable trading day;


•	during the five business day period after any five consecutive trading day period (the "2026 measurement period") in which the trading price per $1,000 principal amount of the 2026 Notes for each trading day of the 2026 measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the notes on each such trading day;


•	if we call any or all of the 2026 Notes for redemption, at any time prior to the close of business on the second business day immediately preceding the relevant redemption date; or


•	upon the occurrence of specified corporate events, as specified in each indenture governing the 2026 Notes.

On or after September 15, 2026 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert the 2026 Notes at any time. Upon conversion, we may satisfy our conversion obligation in cash, shares of common stock or a combination of cash and shares of common stock, at our election.

We may redeem for cash, stock or combination of both for all or any portion of the 2026 Notes, at our option, on or after December 20, 2023, if the last reported sale price of its common stock has been at least 130% of the conversion price then in effect

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide a notice of redemption at a redemption price equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the 2026 Notes. Upon the occurrence of a fundamental change (as defined in the 2026 Indenture), holders may require us to repurchase all or a portion of the 2026 Notes for cash at a price equal to 100% of the principal amount of the 2026 Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

In accordance with accounting for debt with conversions and other options, we bifurcated the principal amount of the 2026 Notes into liability and equity components. The liability component of the 2026 Notes was valued at $734.8 million based on the contractual cash flows discounted at an appropriate comparable market non-convertible debt borrowing rate at the date of issuance of 5.8% with the equity component representing the residual amount of the proceeds of $315.2 million, which was recorded as a debt discount.

We incurred approximately $7.8 million in transaction costs in connection with the issuance of the 2026 Notes and these costs were allocated pro rata based on the relative carrying amounts of the liability and equity components. The debt discount and debt issuance costs attributable to the liability component will be amortized to interest expense using an effective interest rate of 5.8% over the expected life of the 2026 Notes. Debt issuance costs attributable to the equity component are netted with the equity component in stockholders’ equity, and the equity component is not remeasured as long as it continues to meet the conditions for equity classification.

2024 Notes

In March 2017, we issued $450.0 million of the 2024 Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2024 Notes are governed by an indenture between the Company, as the issuer, and U.S. Bank National Association, as trustee (the “2024 Indenture”). The 2024 Notes are unsecured and do not contain any financial covenants, restrictions on dividends, incurrence of senior debt or other indebtedness, or the issuance or repurchase of securities by us.

The 2024 Notes bear interest at a rate of 0.25% per year. Interest on the 2024 Notes is payable semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2017. The 2024 Notes will mature on March 15, 2024, unless earlier repurchased by us or converted pursuant to their terms.

The initial conversion rate of the 2024 Notes is 16.4965 shares of common stock per $1,000 principal amount of 2024 Notes, which is equivalent to an initial conversion price of approximately $60.62 per share, a 132.5% premium to the fair market value at the date of issuance.

Prior to the close of business on the business day immediately preceding December 15, 2023, each holder of the 2024 Notes may convert their 2024 Notes only under the following circumstances:

•

during any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price, or $78.80 on each applicable trading day;


•	during the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of our common stock and the applicable conversion rate on each such trading day; or


•	upon the occurrence of specified corporate events.

On or after December 15, 2023 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2024 Notes at any time. In addition, upon the occurrence of a make-whole fundamental change (as defined in the 2024 Indenture), we will, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert 2024 Notes in connection with such make-whole fundamental change.

We may not redeem the 2024 Notes prior to their maturity date and no sinking fund is provided for the 2024 Notes. Upon the occurrence of a fundamental change, holders may require us to repurchase all or a portion of their 2024 Notes for cash at a price equal to 100% of the principal amount of the 2024 Notes to be repurchased, plus any accrued and unpaid interest.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

We considered the features embedded in the 2024 Notes other than the conversion feature, including the holders’ put feature, our call feature, and the make-whole feature, and concluded that they are not required to be bifurcated and accounted for separately from the host debt instrument.

Prior to the Tax Matters Agreement settlement condition (“TMA settlement condition”), because we could only settle the 2024 Notes in cash, we determined that the conversion feature met the definition of a derivative liability. We separated the derivative liability from the host debt instrument based on the fair value of the derivative liability. As of the issuance date, March 8, 2017, the derivative liability fair value of $129.9 million was calculated using the binomial valuation approach. The residual principal amount of the 2024 Notes of $320.1 million before issuance costs was allocated to the debt component. We incurred approximately $7.7 million in transaction costs in connection with the issuance of the 2024 Notes. These costs were allocated to the debt component and recognized as a debt discount. We amortize the debt discount, including both the initial value of the derivative liability and the transaction costs, over the term of the 2024 Notes using the effective interest method. The effective interest rate of the 2024 Notes is 5.4% per year.

During the fiscal year ended July 1, 2017, we satisfied the TMA settlement condition. As such, the value of the conversion option will no longer be marked to market and was reclassified to additional paid-in capital within stockholders’ equity on our condensed consolidated balance sheet. The value of the conversion option at the time of issuance will be treated as an original issue discount for purposes of accounting for the debt component of the 2024 Notes. The debt component will accrete up to the principal amount over the expected term of the debt.

Our convertible notes consisted of the following components as of the periods presented (in millions):



Liability component:	March 28, 2020						June 29, 2019
	2024 Notes			2026 Notes			2024 Notes
Principal	$	450.0		$	1,050.0		$	450.0
Unamortized debt discount and debt issuance costs	(84.2		)	(309.8		)	(98.1		)
Net carrying amount of the liability component	$	365.8		$	740.2		$	351.9

The following table sets forth interest expense information related to the convertible notes for the periods presented (in millions):



	Three Months Ended				Nine Months Ended
	March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019
Contractual interest expense	$	1.6	$	0.3	$	2.3	$	0.9
Amortization of the debt discount and debt issuance costs	14.0		4.5		24.8		13.2
Total interest expense	$	15.6	$	4.8	$	27.1	$	14.1

The future interest and principal payments related to our convertible notes are as follows as of March 28, 2020 (in millions):



Fiscal Years	2024 Notes		2026 Notes		Total
Remainder of 2020	$	—	$	2.7	$	2.7
2021	1.1		5.2		6.3
2022	1.1		5.3		6.4
2023	1.1		5.2		6.3
2024	451.2		5.3		456.5
Thereafter	—		1,063.1		1,063.1
Total convertible notes payments	$	454.5	$	1,086.8	$	1,541.3

Term Loan Facility

On December 10, 2018 (the “Closing Date”), concurrent with the closing of the Oclaro merger, we entered into a Credit and Guarantee Agreement (the “Credit Agreement”), by and among us, certain of our subsidiaries, the lenders party thereto, and

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Deutsche Bank, as administrative agent and collateral agent for the lenders. The Credit Agreement provides for a senior secured term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $500.0 million. The term loans available under the Term Loan Facility were fully drawn on the Closing Date and the proceeds of the term loans were used to consummate the merger and pay fees and expenses in connection with the merger and the Term Loan Facility.

In fiscal 2019, we incurred $9.3 million of debt issuance costs in connection with the Term Loan Facility which were capitalized and recorded as a contra liability in our condensed consolidated balance sheet. These costs were amortized to interest expense using the effective interest rate method from the issuance date of December 10, 2018.

In fiscal 2020, we repaid, in full, all amounts outstanding under our Term Loan Facility. During the nine months ended March 28, 2020, we incurred an $8.0 million loss for the unamortized debt issuance costs as a result of this full repayment.

The following table sets forth interest expense information related to the term loan for the periods presented (in millions):



	Three Months Ended				Nine Months Ended
	March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019
Contractual interest expense	$	—	$	6.2	$	9.6	$	10.2
Amortization of the debt issuance costs	—		0.4		0.5		0.5
Loss on early extinguishment of debt	—		—		8.0		—
Total interest expense	$	—	$	6.6	$	18.1	$	10.7

For the nine months ended March 28, 2020, we also recorded $0.1 million interest expense related to our finance leases.

The following table sets forth balance sheet information related to the term loan as of the periods presented (in millions):



	March 28, 2020			June 29, 2019
Principal	$	497.5		$	500.0
Repayment of principal	(497.5		)	(2.5		)
Unamortized value of the debt issuance costs	—			(8.5		)
Net carrying value	$	—		$	489.0

Term loan, current	$	—		$	5.0
Term loan, non-current	$	—		$	484.0

Note 13. Accumulated Other Comprehensive Income (Loss)

Our accumulated other comprehensive income (loss) consists of the accumulated net unrealized gains or losses on foreign currency translation adjustments, the defined benefit obligations, and available-for-sale securities.

The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period presented were as follows (in millions):

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)



	Foreign currency translation adjustments, net of tax ⁽¹⁾			Defined benefit obligations, net of tax ⁽²⁾			Unrealized gain (loss) on available-for-sale securities, net of tax ⁽³⁾			Total
Beginning balance as of June 29, 2019 ⁽³⁾	$	9.7		$	(3.5	)	$	0.9		$	7.1
Other comprehensive income	—			—			0.1			0.1
Ending balance as of September 28, 2019 ⁽³⁾	9.7			(3.5		)	1.0			7.2
Other comprehensive loss	—			—			(0.2		)	(0.2		)
Ending balance as of December 28, 2019 ⁽³⁾	9.7			(3.5		)	0.8			7.0
Other comprehensive loss	—			—			(1.2		)	(1.2		)
Ending balance as of March 28, 2020 ⁽³⁾	$	9.7		$	(3.5	)	$	(0.4	)	$	5.8

Beginning balance as of June 30, 2018	$	10.3		$	(2.3	)	$	(1.6	)	$	6.4
Other comprehensive income	0.1			—			0.4			0.5
Ending balance as of September 29, 2018	10.4			(2.3		)	(1.2		)	6.9
Other comprehensive income (loss)	(0.7		)	(0.1		)	0.1			(0.7		)
Ending balance as of December 29, 2018	9.7			(2.4		)	(1.1		)	6.2
Other comprehensive income	—			—			1.3			1.3
Ending balance as of March 30, 2019	$	9.7		$	(2.4	)	$	0.2		$	7.5

(1) In fiscal 2019, as a result of significant changes in economic facts and circumstances, primarily due to the acquisition of Oclaro, we established the functional currency for our worldwide operations as the U.S. dollar. Translation adjustments reported prior to December 10, 2018, remain as a component of accumulated other comprehensive income in our condensed consolidated balance sheets, until all or a part of the investment in the subsidiaries is sold or liquidated.

(2) We evaluate the assumptions over the fair value of our defined benefit obligations annually and make changes as necessary.

(3) Fiscal 2020 balances of unrealized gain (loss) on available-for-sale securities are net of tax of $0.2 million.

Note 14. Restructuring and Related Charges

We have initiated various strategic restructuring actions primarily intended to reduce costs, consolidate our operations, streamline the manufacturing of our products and align our business in response to market conditions and as a result of our acquisition of Oclaro on December 10, 2018.

The following table summarizes the activity of restructuring and related charges during the three and nine months ended March 28, 2020 and March 30, 2019 (in millions):



	Three Months Ended						Nine Months Ended
	March 28, 2020			March 30, 2019			March 28, 2020			March 30, 2019
Balance as of beginning of period	$	5.0		$	3.5		$	14.6		$	1.9
Charges	2.7			21.1			4.9			30.2
Payments	(5.1		)	(6.6		)	(16.9		)	(14.1		)
Balance as of end of period	$	2.6		$	18.0		$	2.6		$	18.0

During the three and nine months ended March 28, 2020, we recorded $2.7 million and $4.9 million, respectively, in restructuring and related charges in our condensed consolidated statements of operations. The charges were mainly attributable to severance charges associated with the decision to move certain manufacturing from San Jose, California to our facility in Thailand.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

resulting in $18.0 million of severance charges and $1.6 million of lease restructuring charges. During the three and nine months ended March 30, 2019, we also recorded restructuring charges primarily associated with acquisition related synergies. In addition, the nine month period charges included severance and employee related benefits associated with Oclaro’s executive severance and retention agreements. These retention agreements provided, under certain circumstances, for payments and benefits upon an involuntary termination of employment.

Any changes in the estimates of executing our restructuring activities will be reflected in our future results of operations.

Note 15. Income Taxes

Our tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, we make a cumulative adjustment in such period. Our quarterly tax provision and estimate of our annual effective tax rate are subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how we do business, and tax law developments.

We recorded a tax provision of $5.2 million and $19.6 million for the three and nine months ended March 28, 2020, respectively. We recognized a discrete tax benefit of $4.1 million during the three months ended March 28, 2020 from the release of uncertain tax positions related to the fiscal 2016 U.S. federal income tax return as a result of the expiration of statute of limitations during the quarter. Our estimated effective tax rate for fiscal 2020 differs from the 21% U.S. statutory rate primarily due to the income tax benefit of the earnings of our foreign subsidiaries being taxed at rates that differ from the U.S. statutory rate as well as the U.S. federal R&D and foreign tax credits, partially offset by the income tax expense from non-deductible stock-based compensation and the tax effect of Global Intangible Low-Taxed Income (“GILTI”), Base Erosion and Anti-Abuse Tax (“BEAT”), and subpart F inclusion.

As of March 28, 2020, we had $18.1 million of unrecognized tax benefits, which, if recognized, would affect the effective tax rate. We are subject to examination of income tax returns by various domestic and foreign tax authorities. The timing of commencement, resolution and closure of tax audits is highly unpredictable. Although it is possible that certain ongoing tax audits may be concluded within the next 12 months, we cannot reasonably estimate the impact to tax expense and net income from tax exams that could be resolved or closed within the next 12 months. Subject to audit timing and uncertainty, we expect our unrecognized tax benefit amount that could affect the effective tax rate to decrease by $1.2 million over the next 12 months.

We believe that we have adequately provided under GAAP for potential outcomes related to our tax audits. However, there can be no assurances as to the possible outcomes or any related financial statement effect thereof.

On June 7, 2019, the U.S. Court of Appeals for the Ninth Circuit, reversing a previous decision of the U.S. Tax Court, held that the U.S. Treasury Department’s regulations requiring the inclusion of stock-based compensation expense in a taxpayer’s cost-sharing calculations were valid. On November 12, 2019, the U.S. Court of Appeals for the Ninth Circuit denied the en banc rehearing request filed by the taxpayer on July 22, 2019. Our financial statements have been prepared consistent with this outcome, but we will continue to monitor any ongoing developments, including a potential appeal to the U.S. Supreme Court, to determine if future changes are required.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020 and accelerates a corporation’s ability to recover AMT refundable credits. The Company is currently evaluating the impact of the CARES Act, but at present does not expect that the provisions of the CARES Act would result in a material cash benefit.

Note 16. Stockholders' Equity

Description of Lumentum Stock-Based Benefit Plans

Equity Incentive Plan

As of March 28, 2020, we had 2.4 million shares subject to stock options, restricted stock units, restricted stock awards, and performance stock units issued and outstanding under the 2015 Equity Incentive Plan (the “2015 Plan”).

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Restricted stock units, restricted stock awards and performance stock units are performance-based, time-based or a combination of both. The fair value of these grants is based on the closing market price of our common stock on the date of award.

As of March 28, 2020, 3.6 million shares of common stock under the 2015 Plan were available for grant.

Restricted Stock Units

Restricted stock units (“RSUs”) under the 2015 Plan are grants of shares of our common stock, the vesting of which is based on the requisite service requirement. Generally, our RSUs are subject to forfeiture and are expected to vest over one to four years. For annual refresh grants, RSUs generally vest ratably on an annual, or combination of annual and quarterly, basis over three years.

Restricted Stock Awards

Restricted stock awards (“RSAs”) under the 2015 Plan are grants of shares of our common stock that are subject to various restrictions, including restrictions on transferability and forfeiture provisions. RSAs are expected to vest over one to four years, and the shares acquired may not be transferred by the holder until the vesting conditions (if any) are satisfied.

Performance Stock Units

Performance stock units (“PSUs”) under the 2015 Plan are grants of shares of our common stock that vest upon the achievement of certain performance and service conditions. We begin recognizing compensation expense when we conclude that it is probable that the performance conditions will be achieved. We reassess the probability of vesting at each reporting period and adjust our compensation cost based on this probability assessment. Our PSUs are subject to risk of forfeiture until performance and service conditions are satisfied and generally vest over three years.

Employee Stock Purchase Plan

Our 2015 Employee Stock Purchase Plan (the “2015 Purchase Plan”) provides eligible employees with the opportunity to acquire an ownership interest in the Company through periodic payroll deductions and provides a 15% purchase price discount as well as a six-month look-back period. The 2015 Purchase Plan is structured as a qualified employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986. The 2015 Purchase Plan will terminate upon the date on which all shares available for issuance have been sold. Of the 3.0 million shares authorized under the 2015 Purchase Plan, 1.9 million shares remained available for issuance as of March 28, 2020.

Stock-Based Compensation Expense

The impact on our results of operations of recording stock-based compensation by function for the three and nine months ended March 28, 2020 was as follows (in millions):



	Three Months Ended				Nine Months Ended
	March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019
Cost of sales	$	4.3	$	3.2	$	12.6	$	11.7
Research and development	4.2		4.5		12.1		10.7
Selling, general and administrative	10.7		8.3		31.4		34.1
Total stock-based compensation	$	19.2	$	16.0	$	56.1	$	56.5

Total income tax benefit associated with stock-based compensation recognized in our consolidated statements of operations during the years presented was as follows (in millions):



	Three Months Ended				Nine Months Ended
	March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019
Income tax benefit associated with stock-based compensation	$	2.4	$	2.1	$	9.0	$	8.8

Approximately $3.0 million and $3.5 million of stock-based compensation was capitalized to inventory as of March 28, 2020 and June 29, 2019, respectively.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Stock Award Activity

The following table summarizes our awards activity for the nine months ended March 28, 2020 (in millions, except per share amounts):



	Restricted Stock Units				Restricted Stock Awards			Performance Stock Units
	Number of Shares		Weighted-Average Grant Date Fair Value per Share		Number of Shares	Weighted-Average Grant Date Fair Value per Share		Number of Shares		Weighted-Average Grant Date Fair Value per Share
Balance as of June 29, 2019	2.2		$	52.4	—	$	32.5	0.2		$	56.0
Granted	1.0		59.3		—	—		0.2		61.9
Vested/Exercised	(1.0	)	52.1		—	32.5		(0.1	)	54.6
Canceled	(0.2	)	51.7		—	—		—		57.3
Balance as of March 28, 2020	2.0		$	55.6	—	$	—	0.3		$	60.2

As of March 28, 2020, $111.6 million of stock-based compensation cost related to awards granted to our employees remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 1.9 years.

A summary of awards available for grant is as follows (in millions):



	Awards Available for Grant
Balance as of June 29, 2019	4.7
Granted	(1.2	)
Canceled	0.1
Balance as of March 28, 2020	3.6

Employee Stock Purchase Plan Activity

The 2015 Purchase Plan expense for each of the three months ended March 28, 2020 and March 30, 2019 was $0.8 million and $1.1 million, respectively. The 2015 Purchase Plan expense for the nine months ended March 28, 2020 and March 30, 2019 was $2.5 million and $2.9 million, respectively. The expense related to the 2015 Purchase Plan is recorded on a straight-line basis over the relevant subscription period. During the three and nine months ended March 28, 2020 there were 0.1 million shares issued to employees through the 2015 Purchase Plan.

We estimate the fair value of the 2015 Purchase Plan shares on the date of grant using the Black-Scholes option-pricing model. During each of the three and nine months ended March 28, 2020 and March 30, 2019, the assumptions used to estimate the fair value of the 2015 Purchase Plan shares to be issued were as follows:



	March 28, 2020		March 30, 2019
Expected term (years)	0.5		0.5
Expected volatility	44.6	%	71.3	%
Risk-free interest rate	1.59	%	2.52	%
Dividend yield	—	%	—	%

Repurchase and Retirement of Common Stock

In December 2019, concurrently with the issuance of the 2026 Notes, we repurchased 2.9 million shares of our common stock in privately negotiated transactions at an average price of $69.68 per share for an aggregate purchase price of $200 million. These shares were retired immediately.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Note 17. Commitments and Contingencies

Purchase Obligations

Purchase obligations of $257.2 million as of March 28, 2020, represent legally-binding commitments to purchase inventory and other commitments made in the normal course of business to meet operational requirements.

Although open purchase orders are considered enforceable and legally binding, the terms generally allow the option to cancel, reschedule and adjust the requirements based on our business needs prior to the delivery of goods or performance of services. Obligations to purchase inventory and other commitments are generally expected to be fulfilled within one year.

We depend on a limited number of contract manufacturers, subcontractors and suppliers for raw materials, packages and standard components. We generally purchase these single or limited source products through standard purchase orders or one-year supply agreements and have no significant long-term guaranteed supply agreements with such vendors. While we seek to maintain a sufficient safety stock of such products and maintain on-going communications with our suppliers to guard against interruptions or cessation of supply, our business and results of operations could be adversely affected by a stoppage or delay of supply, substitution of more expensive or less reliable products, receipt of defective parts or contaminated materials, increases in the price of such supplies, or our inability to obtain reduced pricing from our suppliers in response to competitive pressures.

Product Warranties

We provide reserves for the estimated costs of product warranties at the time revenue is recognized. We typically offer a twelve month warranty for most of our products. However, in some instances depending upon the product, product components or application of our products by the end customer, our warranties can vary and generally range from six months to five years. We estimate the costs of our warranty obligations on an annualized basis based on our historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise with specific products. We assess the adequacy of our recorded warranty liabilities and adjust the amounts as necessary.

The following table presents the changes in our warranty reserve during the three and nine months ended March 28, 2020 and March 30, 2019 (in millions):



	Three Months Ended						Nine Months Ended
	March 28, 2020			March 30, 2019			March 28, 2020			March 30, 2019
Balance as of beginning of period	$	6.8		$	9.7		$	7.5		$	6.6
Warranties assumed in Oclaro acquisition	—			—			—			3.8
Provision for warranty	0.7			1.5			2.5			3.4
Utilization of reserve	(2.1		)	(1.4		)	(4.6		)	(4.0		)
Balance as of end of period	$	5.4		$	9.8		$	5.4		$	9.8

Environmental Liabilities

Our research and development (“R&D”), manufacturing and distribution operations involve the use of hazardous substances and are regulated under international, federal, state and local laws governing health and safety and the environment. We apply strict standards for protection of the environment and occupational health and safety to sites inside and outside the United States, even if not subject to regulations imposed by foreign governments. We believe that our properties and operations at our facilities comply in all material respects with applicable environmental laws and occupational health and safety laws. However, the risk of environmental liabilities cannot be completely eliminated and there can be no assurance that the application of environmental and health and safety laws will not require us to incur significant expenditures. We are also regulated under a number of international, federal, state and local laws regarding recycling, product packaging and product content requirements. The environmental, product content/disposal and recycling laws are gradually becoming more stringent and may cause us to incur significant expenditures in the future.

Legal Proceedings

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

impact on our financial position, results of operations or statements of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. We accrue for loss contingencies when it is both probable that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. We have recorded $1.0 million of litigation contingency in other current liabilities on the condensed consolidated balance sheet as of March 28, 2020.

Merger Litigation

In connection with our acquisition of Oclaro, seven lawsuits were filed by purported stockholders of Oclaro challenging the proposed merger (the “Merger”). Two of the seven suits were putative class actions filed against Oclaro, its directors, Lumentum, Prota Merger Sub, Inc. and Prota Merger, LLC: Nicholas Neinast v. Oclaro, Inc., et al., No. 3:18-cv-03112-VC, in the United States District Court for the Northern District of California (filed May 24, 2018) (the “Neinast Lawsuit”); and Adam Franchi v. Oclaro, Inc., et al., No. 1:18-cv-00817-GMS, in the United States District Court for the District of Delaware (filed June 9, 2018) (the “Franchi Lawsuit”). Both the Neinstat Lawsuit and the Franchi Lawsuit were voluntarily dismissed with prejudice.

The other five suits, styled as Gerald F. Wordehoff v. Oclaro, Inc., et al., No. 5:18-cv-03148-NC (the “Wordehoff Lawsuit”), Walter Ryan v. Oclaro, Inc., et al., No. 3:18-cv-03174-VC (the “Ryan Lawsuit”), Jayme Walker v. Oclaro, Inc., et al., No. 5:18-cv-03203-EJD (the “Walker Lawsuit”), Kevin Garcia v. Oclaro, Inc., et al., No. 5:18-cv-03262-VKD (the “Garcia Lawsuit”), and SaiSravan B. Karri v. Oclaro, Inc., et al., No. 3:18-cv-03435-JD (the “Karri Lawsuit” and, together with the other six lawsuits, the “Lawsuits”), were filed in the United States District Court for the Northern District of California on May 25, 2018, May 29, 2018, May 30, 2018, May 31, 2018, and June 9, 2018, respectively. These five Lawsuits named Oclaro and its directors as defendants only and did not name Lumentum. The Wordehoff, Ryan, Walker, and Garcia Lawsuits have been voluntarily dismissed, and the Wordehoff, Ryan, and Walker dismissals were with prejudice. The Karri Lawsuit has not yet been dismissed. The Ryan Lawsuit was, and the Karri Lawsuit is, a putative class action.

The Lawsuits generally alleged, among other things, that Oclaro and its directors violated Section 14(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 14a-9 promulgated thereunder by disseminating an incomplete and misleading Form S-4, including proxy statement/prospectus. The Lawsuits further alleged that Oclaro’s directors violated Section 20(a) of the Exchange Act by failing to exercise proper control over the person(s) who violated Section 14(a) of the Exchange Act.

The remaining Lawsuit (the Karri Lawsuit) currently purports to seek, among other things, damages to be awarded to the plaintiff and any class, if a class is certified, and litigation costs, including attorneys’ fees. A lead plaintiff and counsel has been selected, and an amended complaint was filed on April 15, 2019, which also names Lumentum as a defendant. A motion to dismiss the amended complaint has been fully briefed and is currently pending, and defendants intend to defend the Karri Lawsuit vigorously.

Indemnifications

In the normal course of business, we enter into agreements that contain a variety of representations and warranties and provide for general indemnification. Exposure under these agreements is unknown because claims may be made against us in the future and we may record charges in the future as a result of these indemnification obligations. As of March 28, 2020, we did not have any material indemnification claims that were probable or reasonably possible.

Audit Proceedings

We are under audit by various domestic and foreign tax authorities with regards to income tax and indirect tax matters. In some, although not all cases, we have reserved for potential adjustments to our provision for income taxes and accrual of indirect taxes that may result from examinations by these tax authorities or final outcomes in judicial proceedings, and we believe that the final outcome of these examinations, agreements or judicial proceedings will not have a material effect on our results of operations. If events occur which indicate payment of these amounts is unnecessary, the reversal of the liabilities would result in the recognition of benefits in the period we determine the liabilities are no longer necessary. If our estimates of the federal, state, and foreign income tax liabilities and indirect tax liabilities are less than the ultimate assessment, it could result in a further charge to expense.

In connection with our acquisition of Oclaro, we recorded $1.1 million in Malaysia Goods and Services Tax (“GST”) refund claims within prepaid expenses and other current assets in our condensed consolidated balance sheet. The refund claim represents an initial claim of $2.5 million of GST, net of reserves, that was previously denied by the Malaysian tax authorities in 2016. During the nine months ended March 28, 2020, we were able to favorably resolve this audit and received refunds for all of our outstanding GST claims.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

Note 18. Operating Segments and Geographic Information

Our chief executive officer is our Chief Operating Decision Maker (“CODM”). The CODM allocates resources to the segments based on their business prospects, competitive factors, net revenue and gross margin. We do not track all of our property, plant and equipment by operating segments. The geographic identification of these assets is set forth below.

We are an industry leading provider of optical and photonic products defined by revenue and market share addressing a range of end-market applications including optical communications and commercial lasers. We have two operating segments, Optical Communications, which we refer to as OpComms, and Commercial Lasers, which we refer to as Lasers. Our OpComms products address the following markets: telecommunications and data communications (“Telecom and Datacom”), and consumer and industrial (“Consumer and Industrial”), and include product lines from the recent acquisition of Oclaro. The two operating segments were primarily determined based on how the CODM views and evaluates our operations. Operating results are regularly reviewed by the CODM to make decisions about resources to be allocated to the segments and to assess their performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and manufacturing, are considered in determining the formation of these operating segments.

We do not allocate research and development, sales and marketing, or general and administrative expenses to our segments because management does not include the information in its measurement of the performance of the operating segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, stock-based compensation and certain other charges impacting the gross margin of each segment because management does not include this information in its measurement of the performance of the operating segments.

Information on reportable segments utilized by our CODM is as follows (in millions):



	Three Months Ended						Nine Months Ended
	March 28, 2020			March 30, 2019			March 28, 2020			March 30, 2019
Net revenue:
OpComms	$	359.3		$	377.9		$	1,184.8		$	1,013.4
Lasers	43.5			55.0			125.7			147.3
Net revenue	$	402.8		$	432.9		$	1,310.5		$	1,160.7
Gross profit:
OpComms	$	161.8		$	143.5		$	550.1		$	397.5
Lasers	21.6			25.3			56.2			63.6
Total segment gross profit	183.4			168.8			606.3			461.1
Unallocated corporate items:
Stock-based compensation	(4.3		)	(3.2		)	(12.6		)	(11.7		)
Amortization of acquired intangibles	(13.9		)	(28.1		)	(38.8		)	(33.3		)
Amortization of fair value adjustments	(1.5		)	(14.5		)	(5.8		)	(15.8		)
Inventory and fixed asset write down due to product lines exit	(2.3		)	(19.4		)	(6.0		)	(19.4		)
Integration related costs	0.3			(2.8		)	(3.1		)	(2.8		)
Other charges ⁽¹⁾	(4.0		)	(12.5		)	(25.5		)	(39.0		)
Gross profit	$	157.7		$	88.3		$	514.5		$	339.1

(1) “Other charges” of unallocated corporate items for the three and nine months ended March 28, 2020 primarily include costs of transferring product lines to new production facilities, including Thailand of $0.4 million and $8.5 million, respectively. We also incurred excess and obsolete inventory charges driven by the decline in demand from Huawei of $0.1 million and $12.8 million during the three and nine months ended March 28, 2020. In addition, there were expenses of $1.6 million related to COVID-19 outbreak during the three and nine months ended March 28, 2020, which include incremental costs for payroll expense such as overtime pay, facilities costs such as gloves, masks and temperature gauges, and under-utilized capacity at certain facilities, in which manufacturing output was impacted. These COVID-19 related costs are offset by benefits realized from government credits for employers’ payroll tax.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

During the three and nine months ended March 30, 2019, “other charges” of unallocated corporate items included costs of transferring product lines to Thailand of $12.0 million and $38.7 million, respectively.

Disaggregation of Revenue

We disaggregate revenue by product and by geography. We do not present other levels of disaggregation, such as by type of products, customer, markets, contracts, duration of contracts, timing of transfer of control and sales channels, as this information is not used by our CODM to manage the business.

The table below discloses our total net revenue attributable to each of our two reportable segments. In addition, it discloses the percentage of our total net revenue attributable to our product offerings which serve Telecom and Datacom, and Consumer and Industrial markets which accounted for 10% or more of our total net revenue during the periods presented (in millions, except percentage data):



	Three Months Ended								Nine Months Ended
	March 28, 2020				March 30, 2019				March 28, 2020				March 30, 2019
OpComms:
Telecom and Datacom	$	251.0	62.3	%	$	300.7	69.5	%	$	765.4	58.4	%	$	683.7	58.9	%
Consumer and Industrial	108.3		26.9		77.2		17.8		419.4		32.0		329.7		28.4
Total OpComms	$	359.3	89.2	%	$	377.9	87.3	%	$	1,184.8	90.4	%	$	1,013.4	87.3	%
Lasers	43.5		10.8		55.0		12.7		125.7		9.6		147.3		12.7
Total Revenue	$	402.8			$	432.9			$	1,310.5			$	1,160.7

We operate in three geographic regions: Americas, Asia-Pacific, and EMEA (Europe, Middle East, and Africa). Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which may differ from the location of their end customers. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries that represented 10% or more of our total net revenue (in millions, except percentage data):



	Three Months Ended								Nine Months Ended
	March 28, 2020				March 30, 2019				March 28, 2020				March 30, 2019
	Amount		% of Total		Amount		% of Total		Amount		% of Total		Amount		% of Total
Americas:
United States	$	38.6	9.6	%	$	29.7	6.9	%	$	118.9	9.1	%	$	72.3	6.3	%
Mexico	33.2		8.2		53.5		12.3		88.3		6.7		164.8		14.2
Other Americas	1.4		0.3		0.9		0.2		3.2		0.3		2.7		0.2
Total Americas	$	73.2	18.1	%	$	84.1	19.4	%	$	210.4	16.1	%	$	239.8	20.7	%

Asia-Pacific:
Hong Kong	$	125.9	31.3	%	$	124.1	28.6	%	$	404.2	30.8	%	$	289.6	25.0	%
South Korea	63.3		15.7		23.6		5.5		239.9		18.3		154.9		13.3
Japan	35.8		8.9		50.0		11.6		110.4		8.4		129.2		11.1
Other Asia-Pacific	77.2		19.2		98.4		22.7		248.8		19.0		234.4		20.2
Total Asia-Pacific	$	302.2	75.1	%	$	296.1	68.4	%	$	1,003.3	76.5	%	$	808.1	69.6	%

EMEA	$	27.4	6.8	%	$	52.7	12.2	%	$	96.8	7.4	%	$	112.8	9.7	%

Total net revenue	$	402.8			$	432.9			$	1,310.5			$	1,160.7

During the three and nine months ended March 28, 2020, net revenue from customers outside the United States, based on customer shipping location, represented 90.4% and 90.9% of net revenue, respectively.

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

During the three and nine months ended March 30, 2019, net revenue from customers outside the United States, based on customer shipping location, represented 93.1% and 93.7% of net revenue, respectively.

The increase in our net revenue from the United States during the nine months ended March 28, 2020 compared to the nine months ended March 30, 2019 is mainly due to the acquisition of Oclaro, which had a higher concentration of customers who manufacture in the United States, as well as a change in shipment destination for some shipments to one of our large customers from Mexico to the United States. During the nine months ended March 28, 2020, our net revenue from South Korea increased due to higher demand in 3D sensing products, while net revenue from Hong Kong increased as a result of higher sales of 3D sensing products and Datacom chips.

Transaction Price Allocated to the Remaining Performance Obligations

The following table includes estimated revenue expected to be recognized in the future for backlog related performance obligations that are unsatisfied as of March 28, 2020 (in millions):



	Less than 1 year	1-2 years	Greater than 2 years	Total
Performance obligations	$513.9	$32.7	$—	$546.6

Contract Balances

The following table reflects the changes in contract balances as of March 28, 2020 (in millions, except percentages):



Contract balances	Balance sheet location	March 28, 2020	June 29, 2019	Change	Percentage Change
Accounts receivable, net	Accounts receivable, net	$261.8	$238.0	$23.8	10.0%
Deferred revenue and customer deposits	Other current liabilities	$1.7	$2.9	$(1.2)	(41.4)%

During the three and nine months ended March 28, 2020, our net revenue was concentrated with two customers, who collectively accounted for 37% and 42% of our total net revenue, respectively.

During the three and nine months ended March 30, 2019, our net revenue was concentrated with three customers, who collectively accounted for 44% and 52% of our total net revenue, respectively.

As of March 28, 2020 and June 29, 2019, our accounts receivable balance was concentrated with two and three customers, who collectively represented 27% and 44% of gross accounts receivable, respectively.

Long-lived assets, namely net property, plant and equipment, net, were identified based on the physical location of the assets in the corresponding geographic areas as of the periods indicated (in millions):



	March 28, 2020		June 29, 2019
Property, plant and equipment, net
United States	$	145.8	$	156.2
Thailand	135.3		157.1
China	43.3		33.5
Japan	29.2		28.3
Other countries	56.5		58.2
Total long-lived assets	$	410.1	$	433.3

Table of Contents

LUMENTUM HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

We purchase a substantial portion of our inventory from contract manufacturers and vendors located primarily in Taiwan, Thailand, and Malaysia. During the three and nine months ended March 28, 2020, net inventory purchases which represented 10% or greater of total net purchases, were concentrated with two contract manufacturers, who collectively accounted for 88% and 85% of total net inventory purchases, respectively. During the three and nine months ended March 30, 2019, net inventory purchases were concentrated with three contract manufacturers, who collectively accounted for 85% and 85% of total net inventory purchases, respectively.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion in conjunction with the unaudited condensed consolidated financial statements and the corresponding notes included elsewhere in this Quarterly Report on Form 10-Q (this “Quarterly Report”). This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements. The matters discussed in these forward-looking statements are subject to risk, uncertainties and other factors that could cause actual results to differ materially from those made, projected or implied in the forward-looking statements. Please see “Risk Factors” and “Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with these statements.

Forward-Looking Statements

This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements are based on our current expectations and involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. These statements relate to, among other things, our markets and industry, products and strategy, the impact of the COVID-19 pandemic and related responses of business and governments to the pandemic on our business and results of operations, sales, gross margins, operating expenses, capital expenditures and requirements, liquidity, product development and R&D efforts, manufacturing plans, litigation, effective tax rates and tax reserves, our corporate and financial reporting structure, our plans for growth and innovation, our plans to discontinue certain operations and product lines, our expectations regarding US-China relations, market and regulatory conditions, the successful integration of Oclaro’s business (including personnel), and our expected synergies and non-GAAP earnings accretion from the acquisition of Oclaro, and are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would,” “contemplate,” “believe,” “predict,” “potential” and similar expressions or variations intended to identify forward-looking statements. These statements are based on the beliefs and assumptions of our management, which are in turn based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section entitled “Risk Factors” included under Part II, Item 1A of this Quarterly Report. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

We are an industry-leading provider of optical and photonic products defined by revenue and market share addressing a range of end-market applications including Optical Communications, which we refer to as OpComms, and Lasers for manufacturing, inspection and life-science applications. We seek to use our core optical and photonic technology and our volume manufacturing capability to expand into attractive emerging markets that benefit from advantages that optical or photonics-based solutions provide, including 3D sensing for consumer electronics and diode light sources for a variety of consumer and industrial applications. We have two operating segments, OpComms and Lasers. The two operating segments were primarily determined based on how the Chief Operating Decision Maker (“CODM”) views and evaluates our operations. Operating results are regularly reviewed by the CODM to make decisions about resources to be allocated to the segments and to assess their performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and manufacturing, are considered in determining the formation of these operating segments.

We believe the world is becoming more reliant on ever-increasing amounts of data flowing through optical networks and data centers, which demand new networks and data centers to be built to satisfy this insatiable demand for data. As higher levels of precision, new materials, factory and energy efficiency are being demanded by manufacturers, suppliers of manufacturing tools globally are turning more and more to laser based approaches, including the types of lasers Lumentum supplies. Laser based 3D sensing is a rapidly developing market. The technology enables computer vision applications that enhance security, safety, and new functionality in the electronic devices that people rely on every day. We believe the global markets in which Lumentum participates have fundamentally robust, long-term trends that increase the need for our photonics products and technologies.

On December 10, 2018, we completed the acquisition of Oclaro, a provider of optical components and modules for the long-haul, metro and data center markets. Refer to “Note 4. Business Combinations” in the notes to condensed consolidated financial statements for further discussion of the merger.

Following the acquisition of Oclaro, during our fiscal 2019, we began making several strategic changes to our OpComms business to better position it for growth and profitability. These changes include attaining acquisition cost synergies related to redundant capabilities, the discontinuing of Telecom Lithium Niobate modulators and Datacom transceiver modules because of their muted growth and profitability trends. We expect actions related to these changes to be completed in fiscal 2021. We don’t believe we are diminishing our profit potential in discontinuing and/or selling these product lines. We expect our Indium Phosphide photonic integrated circuits will continue to replace Lithium Niobate modulators over time and focusing on the development and sale of Datacom chips will enable to profitably participate in the growth in the Datacom and 5G wireless markets.

Related to the strategic changes in our OpComms business, we entered into two strategic transactions to sell some of the discontinued product lines. In the second quarter of fiscal year 2020, we entered into an agreement with Advanced Fiber Resources (Zhuhai) Ltd. (“AFR”), a leading provider of passive optical components, to acquire the assets associated with certain Lithium Niobate product lines manufactured by our San Donato site for $17 million. The transaction was closed in the third quarter of fiscal year 2020. For further information regarding this transaction, refer to “Note 5. Assets and Liabilities Held For Sale” in the notes to condensed consolidated financial statements. On April 18, 2019, we closed a transaction selling many of our Datacom transceiver module product lines to Cambridge Industries Group (“CIG”). For further information regarding this transaction, refer to “Note 4. Business Combinations” in the notes to condensed consolidated financial statements.

Impact of COVID-19 to our Business

The outbreak of the COVID-19 has been declared a pandemic by the World Health Organization and continues to spread globally. The spread of COVID-19 has caused public health officials to recommend, and governments to enact, precautions to mitigate the spread of the virus, including travel restrictions and bans, extensive social distancing guidelines and issuing a “shelter-in-place” order in many regions of the world. The pandemic and these related responses have caused, and are expected to continue to cause a global slowdown of economic activity (including the decrease in demand for a broad variety of goods and services), disruptions in global supply chains and significant volatility and disruption of financial markets We have adopted several measures in response to the COVID-19 outbreak including complying with local, state or federal orders that require employees to work from home, instructing employees to work from home in certain jurisdictions, limiting the number of employees onsite which slowed our manufacturing operations in certain countries, enhanced use of personal protective equipment and restricting non-critical business travel by our employees.

In the geographies we have operations, we have in general been deemed an essential business and been permitted to continue manufacturing and new product development operations in a more limited capacity during the pandemic. This stems from our critical role in global supply chains for the world’s communications and health-care systems. Given the rapidly evolving situation, it is difficult to predict precisely when our ability to supply our products will improve or the magnitude and duration of the impact of the COVID-19 pandemic to our markets. The Company will continue to actively monitor the situation and may take further actions altering our business operations that we determine are in the best interests of our employees, customers, communities, business partners, suppliers, and stockholders, or as required by federal, state, or local authorities. It is not clear what the potential

effects any such alterations or modifications may have on our business, including the effects on the Company's customers, employees, and prospects, or on our financial results for the remainder of fiscal year 2020.

While the recent outbreak of the COVID-19 did not have a material adverse effect on our reported results for our third quarter, we are actively monitoring the impact of the coronavirus outbreak. Due to the severity of COVID-19 in the United States and the timing of the most significant responses thereto in March, we believe the impact on our business in the fourth quarter and beyond will be greater than it was in the third quarter of 2020. The extent to which our operations will be impacted by the outbreak will depend largely on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the outbreak and actions by government authorities and private businesses to contain the outbreak or recover from its impact, among other things.

Our primary strategic focus for several years has been technology and product leadership combined with close customer relationships in long-term healthy and growing markets. We believe this strategy is even more apt, and our long-term opportunity is not diminished with COVID-19. We believe there may be long-term opportunities, as the world’s experience with COVID-19 could drive an increasingly digital and virtual world touching all aspects of life and work that increasingly emphasizes communications systems, cloud services, augmented and virtual reality, and enhanced security. Additionally, ever advancing electronic devices are needed to consume, produce, and communicate digital and virtual content. All these trends could drive the need for higher volumes of higher performing optical devices that we could supply. As such, we expect to continue to invest strongly in new products, technology, and customer programs.

For more information on risks associated with the COVID-19 outbreak, see the section titled “Risk Factors” in Item 1A of Part II.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) as set forth in the Financial Accounting Standards Board’s Accounting Standards Codification (“ASC”), and we consider the various staff accounting bulletins and other applicable guidance issued by the United States Securities and Exchange Commission (“SEC”). GAAP, as set forth within the ASC, requires us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are differences between these estimates, judgments or assumptions and actual results, our financial statements will be affected. Our management does not believe COVID-19 will have a significant impact on our critical accounting policies. The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results include the following:

• Inventory Valuation

• Revenue Recognition

• Income Taxes

• Long-lived Asset Valuation

• Business Combinations

• Goodwill

Except for the adoption of ASU 2016-02, Leases (Topic 842) and the resulting changes in our accounting policies and disclosures for lease accounting, there have been no significant changes to our significant accounting policies as of and for the three months ended March 28, 2020, as compared to the significant accounting policies described in our Annual Report on Form 10-K for the year ended June 29, 2019. Refer to “Note 1. Description of Business and Summary of Significant Accounting Policies” for the details of ASU 2016-02 (Topic 842) adoption. Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in Part II, Item 7 of our Annual Report on Form 10-K for our fiscal year ended June 29, 2019 provides a more complete discussion of our critical accounting policies and estimates.

Recently Issued Accounting Pronouncements

Refer to “Note 2. Recently Issued Accounting Pronouncements” in the notes to condensed consolidated financial statements.

Results of Operations

The results of operations for the periods presented are not necessarily indicative of results to be expected for future periods. The following table summarizes selected unaudited condensed consolidated statements of operations items as a percentage of net revenue:



	Three Months Ended				Nine Months Ended
	March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019
Segment net revenue:
OpComms	89.2	%	87.3	%	90.4	%	87.3	%
Lasers	10.8		12.7		9.6		12.7
Net revenue	100.0		100.0		100.0		100.0
Cost of sales	57.4		73.1		57.8		67.9
Amortization of acquired developed technologies	3.5		6.5		3.0		2.9
Gross profit	39.2		20.4		39.3		29.2
Operating expenses:
Research and development	12.1		13.3		11.4		11.6
Selling, general and administrative	15.2		12.8		13.8		13.0
Restructuring and related charges	0.7		4.9		0.4		2.6
Impairment charges	0.6		7.0		0.2		2.7
Total operating expenses	28.6		38.0		25.7		29.9
Income (loss) from operations	10.6		(17.6	)	13.5		(0.7	)
Unrealized gain on derivative liability	—		—		—		0.8
Interest expense	(3.9	)	(2.6	)	(3.5	)	(2.1	)
Other income (expense), net	5.4		1.2		2.1		1.0
Income (loss) before income taxes	12.1		(19.0	)	12.2		(1.0	)
Provision for (benefit from) income taxes	1.3		(1.9	)	1.5		(0.1	)
Net income (loss)	10.8	%	(17.1	)%	10.7	%	(0.9	)%

Financial Data for the three and nine months ended March 28, 2020 and March 30, 2019

The following table summarizes selected unaudited condensed consolidated statements of operations items (in millions, except for percentages):



	Three Months Ended											Nine Months Ended
	March 28, 2020			March 30, 2019			Change			Percentage Change		March 28, 2020			March 30, 2019			Change			Percentage Change
Segment net revenue:
OpComms	$	359.3		$	377.9		$	(18.6	)	(4.9	)%	$	1,184.8		$	1,013.4		$	171.4		16.9	%
Lasers	43.5			55.0			(11.5		)	(20.9	)	125.7			147.3			(21.6		)	(14.7	)
Net revenue	$	402.8		$	432.9		$	(30.1	)	(7.0	)%	$	1,310.5		$	1,160.7		$	149.8		12.9	%

Gross profit	$	157.7		$	88.3		$	69.4		78.6	%	$	514.5		$	339.1		$	175.4		51.7	%
Gross margin	39.2		%	20.4		%						39.3		%	29.2		%

Research and development	$	48.7		$	57.7		$	(9.0	)	(15.6	)%	$	149.6		$	135.1		$	14.5		10.7	%
Percentage of net revenue	12.1		%	13.3		%						11.4		%	11.6		%

Selling, general and administrative	$	61.3		$	55.2		$	6.1		11.1	%	$	180.4		$	150.9		$	29.5		19.5	%
Percentage of net revenue	15.2		%	12.8		%						13.8		%	13.0		%

Restructuring and related charges	$	2.7		$	21.1		$	(18.4	)	(87.2	)%	$	4.9		$	30.2		$	(25.3	)	(83.8	)%
Percentage of net revenue	0.7		%	4.9		%						0.4		%	2.6		%

Impairment charge	$	2.5		$	30.7		$	(28.2	)	(91.9	)%	$	2.5		$	30.7		$	(28.2	)	(91.9	)%
Percentage of net revenue	0.6		%	7.0		%						0.2		%	2.6		%

Net Revenue

Net revenue decreased by $30.1 million, or 7.0%, during the three months ended March 28, 2020 compared to the three months ended March 30, 2019. This decrease was primarily due to the decreased sales of Telecom and Datacom of $49.7 million and Lasers of $11.5 million, offset by increased sales of Consumer and Industrial of $31.1 million.

OpComms net revenue decreased by $18.6 million, or 4.9%, during the three months ended March 28, 2020 compared to the three months ended March 30, 2019. This decrease was primarily due to decreased sales of Telecom products partially offset by higher sales of 3D sensing products for mobile devices. Our Datacom sales slightly decreased, due to the sale of our Datacom transceiver module business, but such decrease was offset by significant increase in sales of Datacom chips.

Lasers net revenue decreased by $11.5 million, or 20.9%, during the three months ended March 28, 2020 compared to the three months ended March 30, 2019, primarily due to lower revenue from kilowatt class fiber lasers.

Net revenue increased by $149.8 million, or 12.9%, during the nine months ended March 28, 2020 compared to the nine months ended March 30, 2019. This increase was primarily due to the increased sales of Telecom and Datacom of $81.7 million and Consumer and Industrial of $89.7 million, offset by decreased sales of Lasers of $21.6 million.

OpComms net revenue increased by $171.4 million, or 16.9%, during the nine months ended March 28, 2020 compared to the nine months ended March 30, 2019. This increase was primarily due to increased sales in Telecom products, driven by the acquisition of Oclaro, as well as increased sales in 3D sensing products for mobile devices.

Lasers net revenue decreased by $21.6 million, or 14.7%, during the nine months ended March 28, 2020 compared to the nine months ended March 30, 2019, primarily due to decreased sales of our kilowatt class fiber lasers.

During the three and nine months ended March 28, 2020, our net revenue was concentrated with two customers, who collectively accounted for 37% and 42% of our total net revenue, respectively.

During the three and nine months ended March 30, 2019, our net revenue was concentrated with three customers, who collectively accounted for 44% and 52% of our total net revenue, respectively.

Although the magnitude of the impact of COVID-19 on our business operations remains uncertain and difficult to predict, and this remains a highly dynamic situation, we have experienced and will continue to experience in subsequent periods, disruptions to our and our customers’ businesses that will adversely impact our business, financial condition and results of operations.

Revenue by Region

We operate in three geographic regions: Americas, Asia-Pacific and EMEA. Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, however, the location of the end customers may differ. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries within those regions that represented 10% or more of our total net revenue (in millions, except for percentages):



	Three Months Ended								Nine Months Ended
	March 28, 2020				March 30, 2019				March 28, 2020				March 30, 2019
	Amount		% of Total		Amount		% of Total		Amount		% of Total		Amount		% of Total
Americas:
United States	$	38.6	9.6	%	$	29.7	6.9	%	$	118.9	9.1	%	$	72.3	6.3	%
Mexico	33.2		8.2		53.5		12.3		88.3		6.7		164.8		14.2
Other Americas	1.4		0.3		0.9		0.2		3.2		0.3		2.7		0.2
Total Americas	$	73.2	18.1	%	$	84.1	19.4	%	$	210.4	16.1	%	$	239.8	20.7	%

Asia-Pacific:
Hong Kong	$	125.9	31.3	%	$	124.1	28.6	%	$	404.2	30.8	%	$	289.6	25.0	%
South Korea	63.3		15.7		23.6		5.5		239.9		18.3		154.9		13.3
Japan	35.8		8.9		50.0		11.6		110.4		8.4		129.2		11.1
Other Asia-Pacific	77.2		19.2		98.4		22.7		248.8		19.0		234.4		20.2
Total Asia-Pacific	$	302.2	75.1	%	$	296.1	68.4	%	$	1,003.3	76.5	%	$	808.1	69.6	%

EMEA	$	27.4	6.8	%	$	52.7	12.2	%	$	96.8	7.4	%	$	112.8	9.7	%

Total net revenue	$	402.8			$	432.9			$	1,310.5			$	1,160.7

For the three and nine months ended March 28, 2020, net revenue from customers outside the United States, based on customer shipping location, represented 90.4% and 90.9% of net revenue, respectively.

For the three and nine months ended March 30, 2019, net revenue from customers outside the United States, based on customer shipping location, represented 93.1% and 93.7% of net revenue, respectively.

Our net revenue is primarily denominated in U.S. dollars, including our net revenue from customers outside the United States as presented above. We expect revenue from customers outside of the United States to continue to be an important part of our overall net revenue and an increasing focus for net revenue growth opportunities. However, regulatory and enforcement actions by the United States and other governmental agencies, as well as changes in tax and trade policies and tariffs, have impacted and may continue to impact net revenue from customers outside the United States.

Gross Margin and Segment Gross Margin

The following table summarizes segment gross margin for the three and nine months ended March 28, 2020 and March 30, 2019 (in millions, except for percentages):



	Three Months Ended										Nine Months Ended
	Gross Profit						Gross Margin				Gross Profit						Gross Margin
	March 28, 2020			March 30, 2019			March 28, 2020		March 30, 2019		March 28, 2020			March 30, 2019			March 28, 2020		March 30, 2019
OpComms	$	161.8		$	143.5		45.0	%	38.0	%	$	550.1		$	397.5		46.4	%	39.2	%
Lasers	21.6			25.3			49.7	%	46.0	%	56.2			63.6			44.7	%	43.2	%
Segment total	$	183.4		$	168.8		45.5	%	39.0	%	$	606.3		$	461.1		46.3	%	39.7	%
Unallocated corporate items:
Stock-based compensation	(4.3		)	(3.2		)					(12.6		)	(11.7		)
Amortization of acquired intangibles	(13.9		)	(28.1		)					(38.8		)	(33.3		)
Amortization of fair value adjustments	(1.5		)	(14.5		)					(5.8		)	(15.8		)
Inventory and fixed asset write down due to product lines exit	(2.3		)	(19.4		)					(6.0		)	(19.4		)
Integration related costs	0.3			(2.8		)					(3.1		)	(2.8		)
Other charges ⁽¹⁾	(4.0		)	(12.5		)					(25.5		)	(39.0		)
Total	$	157.7		$	88.3		39.2	%	20.4	%	$	514.5		$	339.1		39.3	%	29.2	%

The unallocated corporate items for the periods presented include the effects of amortization of acquired developed technologies and other intangibles, share-based compensation and certain other charges. We do not allocate these items to the gross margin for each segment because management does not include such information in measuring the performance of the operating segments.

Gross Margin

Gross margin for the three months ended March 28, 2020 increased to 39.2% from 20.4% for the three months ended March 30, 2019. The increase was primarily driven by better gross margins within Datacom, due to the sale of our Datacom transceiver module business, which had lower margins, and increased revenue from our Datacom chip products, as well as increased revenue from 3D sensing products for mobile devices. In addition, for the three months ended March 28, 2020, we had lower acquisition related costs such as amortization of acquired intangibles of $14.2 million and amortization of fair value adjustments of $13.0 million, as well as lower inventory and fixed asset write down charges due to product lines exit of $17.1 million.

Gross margin for the nine months ended March 28, 2020 increased to 39.3% from 29.2% for the nine months ended March 30, 2019. The increase was primarily driven by better gross margins within Telecom, due to the acquisition of Oclaro, better gross margins within Datacom, due to the sale of our Datacom transceiver module business and increased revenue of our Datacom chip products, which have higher margins, and increased revenue of 3D sensing products for mobile devices. In addition, for the nine months ended March 28, 2020, we had lower amortization of fair value adjustments related to the Oclaro acquisition of $10.0 million, as well as lower inventory and fixed asset write down charges due to product lines exit of $13.4 million.

We sell products in certain markets that are consolidating, undergoing product, architectural and business model transitions, have high customer concentrations, are highly competitive, are price sensitive and/or are affected by customer seasonal and mix variant buying patterns. We expect these factors to continue to result in variability of our gross margin.

Segment Gross Margin

OpComms

OpComms gross margin for the three months ended March 28, 2020 increased to 45.0% from 38.0% for the three months ended March 30, 2019. The increase was primarily driven by better gross margins within Datacom, due to the sale of our Datacom transceiver module business, which had lower than average gross margins, and increased revenue from our higher margin Datacom chip products, which have higher than average gross margins, and increased revenue of 3D sensing products for mobile devices.

OpComms gross margin for the nine months ended March 28, 2020 increased to 46.4% from 39.2% for the nine months ended March 30, 2019. The increase was primarily driven by better gross margins within Telecom, due to the acquisition of Oclaro, better gross margins within Datacom, due to the sale of our lower margin Datacom transceiver module business and increased revenue of our higher margin Datacom chip products, and increased revenue of 3D sensing products for mobile devices.

Lasers

Lasers gross margin for the three months ended March 28, 2020 increased to 49.7% from 46.0% for the three months ended March 30, 2019. This increase was primarily driven by the streamlining of our manufacturing supply chain related to our kilowatt class fiber products.

Lasers gross margin for the nine months ended March 28, 2020 increased to 44.7% from 43.2% for the nine months ended March 30, 2019. This increase was primarily driven by the streamlining of our manufacturing supply chain related to our kilowatt class fiber products.

Research and Development (“R&D”)

R&D expense decreased by $9.0 million, or 15.6%, for the three months ended March 28, 2020 compared to the three months ended March 30, 2019. The decrease in R&D expense was primarily due to the decrease in payroll related expense of $1.9 million and the decrease in R&D materials of $2.3 million, as a result of the sale of our Datacom transceiver module business. In addition, we had $1.8 million increase in non-recurring engineering credits from customers.

R&D expense increased by $14.5 million, or 10.7%, for the nine months ended March 28, 2020 compared to the nine months ended March 30, 2019. The increase in R&D expense was primarily due to the increase of $9.1 million in investments in key product lines and R&D materials. In addition, payroll related expense increased by $8.5 million mainly due to the acquisition of Oclaro, partially offset by the sale of our Datacom transceiver module business. These increases were offset by $2.4 million higher non-recurring engineering credits from customers.

We believe that continuing our investments in R&D is critical to attaining our strategic objectives. Despite the uncertainty related to COVID-19 and the global economic outlook, we currently plan to continue to invest in R&D and new products that we believe will further differentiate us in the marketplace and expect our investment in R&D to increase in absolute dollars in future quarters.

Selling, General and Administrative (“SG&A”)

SG&A expense increased by $6.1 million, or 11.1%, during the three months ended March 28, 2020 compared to the three months ended March 30, 2019. The increase in SG&A expense was primarily due to the increase in payroll related expense of $2.8 million, stock-based compensation of $2.4 million, integration related costs of $3.7 million, offset by lower discretionary travel and trade shows of $2.0 million, primarily due to COVID-19 restrictions.

SG&A expense increased by $29.5 million, or 19.5%, during the nine months ended March 28, 2020 compared to the nine months ended March 30, 2019. The increase in SG&A expense was primarily due to the increase in amortization of intangibles of $14.2 million and integration related costs of $9.8 million as a result of Oclaro acquisition, as well as the increase in payroll related expense of $13.8 million, offset by lower discretionary travel and trade shows, primarily due to COVID-19 restrictions in the three months ended March 28, 2020.

From time to time, we expect to incur non-core expenses, such as mergers and acquisition-related expenses and litigation expenses, which will likely increase our SG&A expenses and potentially impact our profitability expectations in any particular quarter.

Restructuring and Related Charges

We have initiated various strategic restructuring events primarily intended to reduce costs, consolidate our operations, rationalize the manufacturing of our products and align our business in response to market conditions and as a result of our acquisition of Oclaro in the second quarter of fiscal 2019.

During the three and nine months ended March 28, 2020, we recorded $2.7 million and $4.9 million, respectively, in restructuring and related charges in our condensed consolidated statements of operations. The charges were mainly attributable to severance charges associated with the decision to move certain manufacturing activities from San Jose, California to our facility in Thailand.

During the three and nine months ended March 30, 2019, we recorded $21.1 million and $30.2 million, respectively, in restructuring and related charges in our condensed consolidated statements of operations, primarily attributable to severance and employee related benefits associated with the wind down of operations for Lithium Niobate modulators and Datacom modules resulting in $18.0 million of severance charges and $1.6 million of lease restructuring charges. During the three and nine months ended March 30, 2019, we also recorded restructuring charges primarily associated with acquisition related synergies. In addition, the nine month period charges included severance and employee related benefits associated with Oclaro’s executive severance and retention agreements. These retention agreements provided, under certain circumstances, for payments and benefits upon an involuntary termination of employment.

Any changes in the estimates of executing our restructuring activities will be reflected in our future results of operations.

Impairment charges

In the third quarter of fiscal 2019, we announced our plan to discontinue the development of future Datacom transceiver modules which impacted the Milpitas and Shenzhen Datacom module teams. While we expect strong growth in Datacom volumes in the future, gross margins at the transceiver market level are lower due to extreme competition. Following the Oclaro acquisition, we have a differentiated leadership position across a range of photonic chips on which the Datacom, wireless, and access markets critically rely.

During the three and nine months ended March 28, 2020 and March 30, 2019, we recorded $2.5 million, $2.5 million, $30.7 million, and $30.7 million, respectively, in long-lived asset impairment charges in connection with the above plan.

Interest Expense

For the three months ended March 28, 2020 and March 30, 2019, we recorded interest expense of $15.6 million and $11.3 million, respectively. The increase in interest expense during the three months ended March 28, 2020 as compared to the three months ended March 30, 2019 was mainly driven by the increase in amortization of the debt discount and contractual interest expense of $10.8 million due to the issuance of our 0.50% Convertible Notes due in 2026 (the “2026 Notes”), offset by the decrease in contractual interest expense on our term loan facility of $6.2 million, which was fully repaid in the second quarter of fiscal 2020.

For the nine months ended March 28, 2020 and March 30, 2019, we recorded interest expense of $45.3 million and $24.9 million, respectively. The increase in interest expense during the nine months ended March 28, 2020 as compared to the nine months ended March 30, 2019 was mainly driven by amortization of the debt discount and contractual interest expense incurred from our 2026 Notes, as well as the loss on early extinguishment of debt of $8.0 million, which represents the write-off of the issuance costs in conjunction with payback of our term loan facility in the second quarter of fiscal 2020.

Other Income (Expense), Net

The components of other income (expense), net are as follows (in millions):



	Three Months Ended					Nine Months Ended
	March 28, 2020		March 30, 2019			March 28, 2020			March 30, 2019
Foreign exchange gains (losses), net	$	0.7	$	(1.0	)	$	(0.3	)	$	(1.0	)
Interest income	5.2		3.9			12.6			10.0
Other income (expense), net	15.8		2.3			15.6			2.7
Total other income (expense), net	$	21.7	$	5.2		$	27.9		$	11.7

For the three and nine months ended March 28, 2020, other income, net increased by $16.5 million and $16.2 million, respectively, as compared to the three and nine months ended March 30, 2019, mainly driven by a gain on the sale of Lithium Niobate modulators business of $13.8 million. The transaction was completed in the third quarter of fiscal year 2020.

Unrealized Gain on Derivative Liability

We recorded $8.8 million of unrealized gain on Series A Preferred Stock derivative liability for the nine months ended March 30, 2019. On November 2, 2018, all 35,805 shares of our Series A Preferred Stock were converted to common stock with the outstanding balance of the embedded derivative liability reclassified to additional paid in capital. There will be no further adjustments to “unrealized gain (loss) on derivative liability” due to this conversion. For further discussion of our derivative liability, see “Note 11. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability” in the notes to condensed consolidated financial statements.

Provision for (Benefit from) Income Taxes



(in millions)	Three Months Ended					Nine Months Ended
	March 28, 2020		March 30, 2019			March 28, 2020		March 30, 2019
Provision for (benefit from) income taxes	$	5.2	$	(8.2	)	$	19.6	$	(1.6	)

We recorded a tax provision (benefit) of $5.2 million and $(8.2) million for the three months ended March 28, 2020 and March 30, 2019, respectively, and $19.6 million and $(1.6) million for the nine months ended March 28, 2020 and March 30, 2019, respectively. We recognized a discrete tax benefit of $4.1 million during the three months ended March 28, 2020 from the release of uncertain tax positions related to the fiscal 2016 U.S. federal income tax return as a result of the expiration of statute of limitations during the quarter. Our estimated effective tax rate for fiscal 2020 differs from the 21% U.S. statutory rate primarily due to the income tax benefit of the earnings of our foreign subsidiaries being taxed at rates that differ from the U.S. statutory rate as well as the U.S. federal R&D and foreign tax credits, partially offset by the income tax expense from non-deductible stock-based compensation and the tax effect of Global Intangible Low-Taxed Income (“GILTI”), Base Erosion and Anti-Abuse Tax (“BEAT”) and subpart F inclusion.

Contractual Obligations

The following table summarizes our contractual obligations as of March 28, 2020, and the effect such obligations are expected to have on our liquidity and cash flow over the next five years (in millions):



	Payments due by period
	Total		Less than 1 year		1 - 3 years		3 - 5 years		More than 5 years
Contractual Obligations
Asset retirement obligations	$	4.9	$	—	$	1.0	$	1.8	$	2.1
Finance lease liabilities, including imputed interest	4.0		3.9		0.1		—		—
Operating lease liabilities, including imputed interest ⁽¹⁾	80.6		13.5		24.0		16.5		26.6
Pension plan contributions ⁽²⁾	0.5		0.5		—		—		—
Purchase obligations ⁽³⁾	257.2		255.3		1.9		—		—
Convertible notes - principal ⁽⁴⁾	1,500.0		—		—		450.0		1,050.0
Convertible notes - interest ⁽⁴⁾	41.3		5.9		12.7		12.2		10.5
Total	$	1,888.5	$	279.1	$	39.7	$	480.5	$	1,089.2

(1) The amounts of operating lease liabilities in the table above do not include any sublease income amounts nor do they include payments for short-term leases or variable lease payments. As of March 28, 2020, we expect to receive sublease income of approximately $5.9 million over the next three years.

(2) The amount in the preceding table represents planned contributions to our defined benefit plans. Although additional future contributions will be required, the amount and timing of these contributions will be affected by actuarial assumptions, the actual rate of returns on plan assets, the level of market interest rates, legislative changes, and the amount of voluntary contributions to the plan. Any contributions for the following fiscal year and later will depend on the value of the plan assets in the future and thus are uncertain. As such, we have not included any amounts beyond one year in the table above.

(3) Purchase obligations represent legally-binding commitments to purchase inventory and other commitments made in the normal course of business to meet operational requirements. Refer to “Note 17. Commitments and Contingencies” in the notes to condensed consolidated financial statements.

(4) Includes principal and interest on our 0.25% Convertible Notes due in 2024 (the “2024 Notes” and together with the 2026 Notes, the “Notes”) through March 2024, and principal and interest on our 2026 Notes through December 2026. We have the right to redeem the 2024 Notes and the 2026 Notes in whole or in part at any time on or after March 15, 2024 and on or after December 15, 2026, respectively. Refer to “Note 12. Debt” in the notes to condensed consolidated financial statements.

As of March 28, 2020, our other non-current liabilities also include $18.1 million of unrecognized tax benefit for uncertain tax positions. We are unable to reliably estimate the timing of future payments related to uncertain tax positions and therefore have excluded them from the preceding table.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as such term is defined in rules promulgated by the SEC, that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Financial Condition

Liquidity and Capital Resources

As of March 28, 2020 and June 29, 2019, our cash and cash equivalents of $688.3 million and $432.6 million, respectively, were largely held in the United States. The total amount of cash outside the United States as of March 28, 2020 was $84.7 million, which was primarily held by entities incorporated in Japan, the United Kingdom, the British Virgin Islands, Hong Kong, and Thailand. Although the cash currently held in the United States as well as the cash generated in the United States from future operations is expected to cover our normal operating requirements, a substantial amount of additional cash could be required for other purposes, such as capital expenditures to support our business and growth, including costs associated with increasing internal manufacturing capabilities, particularly in our Thailand facility, strategic transactions and partnerships, and future acquisitions. Our intent is to indefinitely reinvest funds held outside the United States, except for the funds held in the Cayman Islands, Japan and Hong Kong, and our current plans do not demonstrate a need to repatriate them to fund our domestic operations. However, if in the future, we encounter a significant need for liquidity domestically or at a particular location that we cannot fulfill through borrowings, equity offerings, or other internal or external sources, or the cost to bring back the money is insignificant from a tax perspective, we may determine that cash repatriations are necessary or desirable. Repatriation could result in additional material taxes. These factors may cause us to have an overall tax rate higher than other companies or higher than our tax rates have been in the past. If conditions warrant, we may seek to obtain additional financing through debt or equity sources. To the extent we issue additional shares, our existing stockholders may be diluted. However, any such financing may not be available on terms favorable to us, or may not be available at all.

As of March 28, 2020, our condensed consolidated balance of cash, cash equivalents, and restricted cash increased by $256.2 million, to $688.8 million from $432.6 million as of June 29, 2019. The increase in cash, cash equivalents, and restricted cash was mainly due to cash provided by operating activities of $401.6 million and cash provided by financing activities of $332.5 million, offset by cash used in investing activities of $477.9 million during the nine months ended March 28, 2020.

As of March 30, 2019, our consolidated balance of cash and cash equivalents, including cash classified within assets held-for-sale, decreased by $39.0 million, to $358.3 million from $397.3 million as of June 30, 2018. The decrease in cash and cash equivalents was mainly due to cash used in investing activities of $725.3 million, principally related to cash used to acquire Oclaro; partially offset by cash provided by financing activities of $484.1 million, primarily related to $490.8 million in proceeds from a term loan, net of debt issuance costs, used to fund the Oclaro acquisition, and cash provided by operating activities of $202.4 million during the nine months ended March 30, 2019.

Operating Cash Flow

Cash provided by operating activities was $401.6 million during the nine months ended March 28, 2020. Our net income was $140.1 million for the nine months ended March 28, 2020. Cash provided by operating activities was generated primarily from $232.8 million of non-cash items (such as depreciation, stock-based compensation, amortization of intangibles, amortization

of debt discount and debt issuance costs on our term loans and convertible notes, and other non-cash charges), and $28.7 million of changes in our operating assets and liabilities. Changes in our operating assets and liabilities related primarily to a decrease in inventories of $48.3 million offset by an increase in accounts receivable of $23.8 million.

Cash provided by operating activities was $202.4 million during the nine months ended March 30, 2019. Our net loss was $10.6 million for the nine months ended March 30, 2019. Cash provided by operating activities was generated primarily from $210.0 million of non-cash items (such as depreciation, stock-based compensation, unrealized (gain) loss on derivative liability, amortization of intangibles, amortization of discount on the 2024 Notes, amortization of the debt issuance costs on the term loan, amortization of fair value adjustment in connection with the acquisition of Oclaro, net amortization of discounts and premium on investments, and impairment charges and others), and $3.0 million of changes in our operating assets and liabilities.

Investing Cash Flow

Cash used in investing activities of $477.9 million during the nine months ended March 28, 2020 was primarily attributable to purchases of short-term investments, net of sales and maturities of $427.9 million, capital expenditures of $64.9 million, and payment for asset acquisition of $4.0 million, offset by proceeds from sale of product lines of $18.9 million.

Cash used in investing activities of $725.3 million during the nine months ended March 30, 2019, was primarily attributable to $619.8 million in cash payments to acquire all outstanding shares of common stock of Oclaro, net of cash received through the acquisition of Oclaro. In addition we had capital expenditures of $80.5 million, payment for asset acquisition of $1.3 million, and purchase of short-term investments, net of sales of $23.7 million.

Financing Cash Flow

Cash provided by financing activities of $332.5 million during the nine months ended March 28, 2020 resulted primarily from the proceeds of the issuance of the 2026 Notes of $1,042.4 million, net of issuance costs, offset by the repurchase of shares of our common stock of $200.0 million and repayment of our term loan facility of $497.5 million.

Cash provided by financing activities of $484.1 million during the nine months ended March 30, 2019, primarily resulted from $490.8 million of proceeds from a term loan, net of debt issuance costs, used to partially finance the Oclaro acquisition, $4.7 million from the issuance of common stock under the employee stock plan; partially offset by the repayment of capital lease obligations of $6.1 million, tax payments related to restricted stock of $2.4 million, a payment of an acquisition related holdback of $1.0 million, and dividend payments on our Series A Preferred Stock of $0.7 million.

Liquidity and Capital Resources Requirements

We believe that our cash and cash equivalents as of March 28, 2020 and cash flows from our operating activities will be sufficient to meet our liquidity and capital spending requirements for at least the next 12 months. However, if market conditions are favorable, we may evaluate alternatives to opportunistically pursue additional financing.

There are a number of factors that could positively or negatively impact our liquidity position, including:


•	global economic conditions which affect demand for our products and services and impact the financial stability of our suppliers and customers, including the impact of COVID-19;


•	fluctuations in demand for our products as a result of changes in regulations, tariffs or other trade barriers, and trade relations in general;


•	changes in accounts receivable, inventory or other operating assets and liabilities, which affect our working capital;


•	increase in capital expenditures to support our business and growth;


•	the tendency of customers to delay payments or to negotiate favorable payment terms to manage their own liquidity positions;


•	timing of payments to our suppliers;


•	factoring or sale of accounts receivable;


•	volatility in fixed income and credit, which impact the liquidity and valuation of our investment portfolios;


•	volatility in foreign exchange markets, which impacts our financial results;


•	possible investments or acquisitions of complementary businesses, products or technologies, or other strategic transactions or partnerships;


•	issuance of debt or equity securities, or other financing transactions, including bank debt;


•	potential funding of pension liabilities either voluntarily or as required by law or regulation; and


•	the settlement of any conversion or redemption of the 2024 Notes and the 2026 Notes in cash.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

COVID-19 Risk

There are a number of market risk factors related to the COVID-19 pandemic and associated global economic impacts. We continue to actively evaluate these risks, and have taken reserves and financial positions as of March 28, 2020 that we believe are reasonable based on the information currently available. However, the COVID-19 pandemic and regional shelters-in-place is an unprecedented phenomenon that is continually evolving, and there could be significant changes and/or charges resulting in the future. These market risks include, for example:


•	Accounts receivable collectability - there could be significant bad debt expenses incurred if our customers experience financial difficulties.


•	Accounts receivable collections timing - our working capital and cash flows could be impacted as companies have started extending payment terms. Although we have not done so, a broader market move to longer payment terms could delay our collection timing as well.


•	Inventory (excess and obsolete) - our customers may not be able to purchase inventory that we have built for them, or their demand may slow down to a point where inventory becomes aged.


•	Short-term investment values - as seen in past economic slowdowns, there may be credit losses and defaults which cause losses and/or liquidity issues in our investment portfolio.


•	Long-term assets such as fixed assets, goodwill, and intangibles - a market slowdown could impair the value of these assets.


•	Tax valuation - we have significant NOL’s (Net Operating losses) in the United States which have associated deferred tax assets on our balance sheet, and these could be deemed unrecoverable in the future.

In addition, all of the below market risks are heightened in light of the current market situation. Foreign exchange markets could be impacted and cause significant fluctuations in our future expenses. The price of our common stock has fluctuated significantly in the past and global equity markets are experiencing significant volatility following the COVID-19 outbreak. Interest rates have already reduced dramatically since the onset of the outbreak, and our future income from these investments likely will be negatively impacted in the future.

Foreign Exchange Risk

We conduct our business and sell our products to customers primarily in Asia, Europe, and North America. Due to the impact of changes in foreign currency exchange rates between the U.S. Dollar and foreign currencies, for the three and nine months ended March 28, 2020, we recorded foreign exchange gains (losses), net of $0.7 million and $(0.3) million, respectively, and for each of the three and nine months ended March 30, 2019, we recorded foreign exchange gains (losses), net of $(1.0) million, in the other income (expense), net in the condensed consolidated statements of operations.

Although we sell primarily in the U.S. Dollar, we have foreign currency exchange risks related to our expenses denominated in currencies other than the U.S. Dollar, principally the Chinese Yuan, Canadian Dollar, Thai Baht, Japanese Yen, UK Pound, Swiss Franc and Euro. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. In the event our foreign currency denominated assets, liabilities, sales or expenses increase, our operating results may be more greatly affected by fluctuations in the exchange rates of the currencies in which we do business.

Equity Price Risk

We are exposed to equity price risk related to the conversion options embedded in our 2026 Notes and 2024 Notes.

We issued the 2026 Notes in December 2019 and the 2024 Notes in March 2017 with an aggregate principal amount of $1,050 million and $450 million, respectively. Both the 2026 Notes and the 2024 Notes are carried at face value less amortized discount on the condensed consolidated balance sheet. The 2026 Notes and the 2024 Notes bear interest at a rate of 0.50% and 0.25% per year, respectively. Since the Notes bear interest at fixed rates, we have no financial statement risk associated with changes in interest rates. However, the potential value of the shares to be distributed to the holders of our Notes changes when the market price of our stock fluctuates. The 2026 Notes will mature on December 15, 2026, unless earlier repurchased by us or converted pursuant to their terms, at a conversion price of approximately $99.29 per share. The 2024 Notes will mature on March 15, 2024, unless earlier repurchased by us or converted pursuant to their terms, at a conversion price of approximately $60.62 per share.

Interest Rate Fluctuation Risk

As of March 28, 2020, we had cash, cash equivalents, and short-term investments of $1,451.4 million. Cash equivalents and short-term investments are primarily comprised of government money market funds, treasuries, and highly liquid investment grade fixed income securities. Our investment policy and strategy is focused on the preservation of capital and supporting our liquidity requirements. We do not enter into investments for trading or speculative purposes. As of March 28, 2020, the weighted-average life of our investment portfolio was less than six months. Our fixed-income portfolio is subject to fluctuations in interest rates, which could affect our results of operations. Based on our investment portfolio balance as of March 28, 2020, a hypothetical increase or decrease in interest rates of 1% (100 basis points) would have resulted in a decrease or an increase in the fair value of our portfolio of approximately $4.1 million, and a hypothetical increase or decrease of 0.50% (50 basis points) would have resulted in a decrease or an increase in the fair value of our portfolio of approximately $2.1 million.

Bank Liquidity Risk

As of March 28, 2020, we had approximately $121.3 million of unrestricted cash (excluding money market funds) in operating accounts that are held with domestic and international financial institutions. These cash balances could be lost or become inaccessible if the underlying financial institutions fail or if they are unable to meet the liquidity requirements of their depositors and they are not supported by the national government of the country in which such financial institution is located. Notwithstanding, to date, we have not incurred any losses and have had full access to our operating accounts. We believe any failures of domestic and international financial institutions could impact our ability to fund our operations in the short term.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

Our management (with the participation of our Principal Executive Officer and Principal Financial Officer), as of the end of the period covered by this Quarterly Report, evaluated the effectiveness of our disclosure controls and procedures. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) were effective to provide reasonable assurance that the information required to be disclosed by us in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), identified in connection with the evaluation required by Exchange Act Rules 13a-15(d) or 15d-15(d) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We continue to integrate Oclaro into our systems and control environment as of March 28, 2020. We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

Inherent Limitations on Effectiveness of Controls

Our management, including the CEO and CFO, recognizes that our disclosure controls and procedures or our internal control over financial reporting cannot prevent or detect all possible instances of errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against us, individually or in the aggregate, will not have a material adverse impact on our financial position, results of operations or cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on our financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

Merger Litigation

ITEM 1A. RISK FACTORS

Investors in our securities should carefully consider all of the relevant factors disclosed by us, including the following factors that could affect our results of operations, financial condition or stock price.

Risks Related to Our Business

The effects of the COVID-19 pandemic have disrupted, and may continue to significantly disrupt, our operations, including our ability to manufacture and supply products and perform research and development activities, which could have a material and adverse effect on our business, future revenues and financial condition. We are unable to predict the extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position and the achievement of our strategic objectives.

Our business, results of operation and financial performance have been negatively impacted by the COVID-19 pandemic and related public health responses, such as shelter-in-place orders, social distancing protocols, and travel restrictions in many of the countries and regions in which we have operations or manufacturing partners.

As a result of the COVID-19 outbreak around the world, Lumentum implemented certain travel restrictions beginning in early February 2020, temporarily closed or limited the number of employees permitted onsite in our offices in several heavily impacted locations, and implemented work-from-home rules at most of our facilities. These measure as well as additional workforce disruptions due to quarantines, governmental actions, and/or the social distancing measures we have taken to mitigate the impact of COVID-19 at certain of our locations around the world in an effort to protect the health and well-being of our employees, customers, suppliers and the communities in which we operate, has caused, and may continue to cause, disruption and delays in our ability to operate and manufacture, test and assemble products in our internal facilities, particularly in California, China, Thailand and the United Kingdom, and has limited our ability to continue certain research and development activities which could materially and adversely affect our ability to develop new products and technologies on the timelines we previously anticipated.

In addition, we have experienced disruption and delays in our supply chain and with our manufacturing partners, primarily in Malaysia, which has imposed and may continue to impose limitations on which businesses may operate and the amount of the workforce permitted to perform manufacturing operations. Our supply chain is experiencing similar issues and may not have the materials, capacity or capability to supply us with the components necessary for continuing our manufacturing operations or development efforts at our normal levels. There are also restrictions and delays on logistics, such as air cargo carriers, as well as increased logistics costs due to limited capacity and high demands for freight forwarders. These disruptions, delays and restrictions have adversely affected our revenue and results of operations and could be extended or further restrictions could be put in place in other regions, which would materially and adversely impact our revenue, results of operations and financial condition.

The COVID-19 pandemic has created economic uncertainty and volatility in the financial markets around the world, resulting in an economic downturn that has affected and may continue to affect demand for our products and impact our results of operations. The ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic (including restrictions on travel and transport and workforce pressures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; and the pace of recovery when the COVID-19 pandemic subsides. Although the magnitude of the impact of COVID-19 on our business operations remains uncertain and difficult to predict, and this remains a highly dynamic situation, we have experienced and will continue to experience in subsequent periods, disruptions to our business that will adversely impact our business, financial condition and results of operations.

Changing technology and intense competition require us to continuously innovate while controlling product costs, and our failure to do so may result in decreased revenues and profitability.

The markets in which we operate are dynamic and complex, and our success depends upon our ability to deliver both our current product offerings and new products and technologies on time and at acceptable prices to our customers. The markets for our products are characterized by rapid technological change, frequent new product introductions, substantial capital investment, changes in customer requirements, continued price pressures and a constantly evolving industry. Historically, these pricing pressures have led to a continued decline of average selling prices across our business. The development of new, technologically advanced products is a complex and uncertain process requiring high levels of innovation and the accurate prediction of technology and market trends, and is further impacted by the disruptions caused by COVID-19 on our ability to continue with research and development activities. The introduction of new products also often requires significant investment to ramp up production capacity, the benefit of which may not be realized if we are not successful in the production of such products or if customer demand does

not develop as expected. Ramping of production capacity also entails risks of delays which can limit our ability to realize the full benefit of new product introductions. We cannot assure you that we will be able to identify, develop, manufacture, market or support new or enhanced products successfully, if at all, or on a timely basis. We also cannot assure you that potential markets for our new products will materialize on the timelines we anticipate, or at all, or that our technology will meet our customers’ specifications. Our future performance will depend on the successful development, introduction, deployment and market acceptance of new and enhanced features and products that meet our customers’ current and future needs.

The market for optical communications products in particular has matured over time and these products have increasingly become subject to commoditization. Both legacy competitors as well as new entrants, predominantly Asia-based competitors, have intensified market competition in recent years leading to pricing pressure. To preserve our revenues and product margin structures, we remain reliant on an integrated customer and market approach that anticipates end customer needs as Telecom and Datacom requirements evolve. We also must continue to develop more advanced, differentiated products that command a premium with customers, while conversely continuing to focus on streamlining product costs for established legacy products. If we fail to continue to develop enhanced or new products, or over time are unable to adjust our cost structure to continue to competitively price more mature products, our financial condition and results of operations could be materially and adversely affected.

We rely on a limited number of customers for a significant portion of our sales; and the majority of our customers do not have contractual purchase commitments.

We have consistently relied on a small number of customers for a significant portion of our sales and in certain of our markets, such as 3D sensing and commercial lasers, this customer concentration is particularly acute. We expect that this customer concentration will continue in the future and we expect that our growth prospects will continue to be concentrated in a small number of customers. Many of our customers purchase products under purchase orders or under contracts that do not contain volume purchase commitments. Some customers provide us with their expected forecasts for our products several months in advance, but these customers may decrease, cancel or delay purchase orders already in place, including on short notice, particularly in light of the impacts of COVID-19 on their businesses and markets, and the impact of any such actions may be intensified given our dependence on a limited number of large customers. In addition, changes in the business requirements, vendor selection, project prioritization, financial prospects, capital resources, and expenditures, or purchasing behavior (including product mix purchased or timing of purchases) of our key customers, or any real or perceived quality issues related to the products that we sell to such customers, could significantly decrease our sales to such customers or could lead to delays or cancellations of planned purchases of our products or services, which increases the risk of quarterly fluctuations in our revenues and operating results. Our relationships with large customers may also be harmed to the extent the impacts of the COVID-19 pandemic prevent us from being able to satisfy their orders in a timely manner. There are also continuing trade tensions, including an uncertain regulatory environment, with the U.S. and countries in Asia, which could materially impact our sales to key customers in these regions. Further, we may be required to purchase raw materials, increase production capacity or make other changes to our business to accommodate certain large customers. If forecasted orders do not materialize, we may need to reduce investment in R&D activities, we may fail to optimize our manufacturing capacity, we may incur liabilities with our suppliers for reimbursement of capital expenditures, or we may have excess inventory. In addition, if we incur expenses in response to forecasted demand and do not have a corresponding increase in revenue, our profitability may suffer. Any of these factors could adversely affect our business, financial condition and results of operations.

Our ability to sell our products to a significant customer has been restricted.

On May 16, 2019, Huawei Technologies Co. Ltd. and 68 designated non-U.S. affiliates (collectively, “Huawei”) were added to the Entity List of the Bureau of Industry and Security of the U.S. Department of Commerce, which imposes limitations on the supply of certain U.S. items and product support to Huawei. We suspended shipments of all products to Huawei until we were able to review our product portfolio and determine whether our products are subject to the Export Administration Regulations (“EAR”), and therefore within the scope of the Entity List restrictions. We resumed shipments of certain of our products to Huawei during the quarter ended June 29, 2019 after determining that such products are not subject to the EAR.

Notwithstanding our determination that we are able to ship certain products in compliance with applicable law, we believe that under the current regulatory regime, our business with Huawei may be more limited than it was in the past. For example, we may be unable to supply certain other products or be limited or unable to work with Huawei on future product development while Huawei remains on the Entity List, which may negatively impact our financial condition and results of operations. Huawei may seek to obtain similar or substitute products from our competitors that are not subject to these restrictions, or to develop similar or substitute products themselves.

Tensions between the governments of the US and China have continued to escalate. We cannot be certain what additional actions the U.S. government may take with respect to Huawei, including changes to the Entity List restrictions, export regulations, tariffs or other trade restrictions. We are unable to predict the duration of the restrictions enacted in May 2019 or of additional

actions, which could have a long-term adverse effect on our business. To the extent that the U.S. government adds other customers of ours to the Entity List or otherwise restricts our ability to ship products to foreign customers or certain jurisdictions, our business, financial condition and results of operations may be harmed.

We also manufacture customized products for Huawei, and therefore may be unable to sell certain finished goods inventory to alternative customers, or may be unable to utilize such manufacturing capabilities for products for alternative customers, which may result in excess and obsolete changes in future periods. Such charges could also occur with respect to customized products we manufacture for other customers should the U.S. government add such customers to the Entity List or otherwise restrict our ability to sell to such customers.

Continued competition in our markets may lead to an accelerated reduction in our prices, revenues and market share.

The end markets for optical products have experienced significant industry consolidation during the past few years. As a result, the markets for optical subsystems, components and laser diodes are highly competitive. Our current competitors include a number of domestic and international public and private companies, many of which may have substantially greater financial, technical, marketing and distribution resources and brand name recognition than we have. Our competitors include II-VI (which acquired Finisar in September 2019), Acacia Communications (which has entered into an agreement to be acquired by Cisco), AMS, Broadcom, Coherent, Fujitsu Optical Components, Furukawa Electric, IPG Photonics, MACOM, Mitsubishi Electric, Molex, Neophotonics, nLight, O-net Communications, OSRAM, Sumitomo Electric Industries and Trumpf. We may not be able to compete successfully against either current or future competitors. Our competitors may continue to enter markets or gain or retain market share through introduction of new or improved products or with aggressive low pricing strategies that may impact the efficacy of our approach. Additionally, if significant competitors were to merge or consolidate, for example, the recently completed acquisition of Finisar by II-VI and the pending acquisition of Acacia Communications by Cisco, they may be able to offer a different market approach, or a lower cost structure through economies of scale or other efficiencies that we may be unable to match and which may intensify competition in the various markets. Increased competition could result in significant price erosion, reduced revenue, lower margins or loss of market share, any of which would significantly harm our business.

The manufacturing of our products may be adversely affected if we are unable to manufacture certain products in our manufacturing facilities or if our contract manufacturers and suppliers fail to meet our production requirements.

We manufacture some of our finished good products as well as some of the components that we provide to our contract manufacturers in our China, Japan, Thailand, U.K., and San Jose, California manufacturing facilities. For some of the components and finished good products we are the sole manufacturer. Our manufacturing processes are highly complex, and issues are often difficult to detect and correct. From time to time we have experienced problems achieving acceptable yields in our manufacturing facilities, resulting in delays in the availability of our products. In addition, if we experience problems with our manufacturing facilities or are unable to continue operations at any of these sites, including as a result of COVID-19 impacts, particularly as our manufacturing is heavily concentrated in central Asia and we would be severely impacted if there were further escalation of COVID-19 in that region, it would be costly and require a long period of time to move the manufacture of these components and finished good products to a different facility or contract manufacturer which could then result in interruptions in supply, and would likely materially impact our financial condition and results of operations.

We also rely on several independent contract manufacturers to supply us with certain products. For many products, a particular contract manufacturer may be the sole source of the finished good products. We depend on these manufacturers to meet our production and capacity requirements and to provide quality products to our customers. If operations at these contract manufacturers is adversely impacted by restrictions due to COVID-19 or any resulting economic impact to their business, this would likely materially impact our financial condition and results of operations.

In addition, despite rigorous testing for quality, both by us and the contract manufacturers to whom we sell products, we may receive and ship defective products. We may incur significant costs to correct defective products which could result in the loss of future sales, indemnification costs or costs to replace or repair the defective products, litigation and damage to our reputation and customer relations. Defective products may also cause diversion of management attention from our business and product development efforts.

Additionally, our ability to fulfill our customers’ demand, or the ability of our contract manufacturers to fulfill their obligations, may be affected by natural disasters, including a global pandemic such as COVID-19, changes in legal requirements, labor strikes and other labor unrest and economic, political or other forces that are beyond our control. For example, in the past we experienced a labor strike at one of our contract manufacturers which threatened the contract manufacturer’s ability to fulfill its product commitments to us and, in turn, our ability to fulfill our obligations to our customers. Further, certain of our contract manufacturers are located in China, which exposes us to risks associated with Chinese laws and regulations and U.S. laws, regulations and policies with respect to China, such as those related to import and export policies, tariffs, taxation and intellectual property. Chinese laws and regulations are subject to frequent change, and if our contract manufacturers are unable to obtain or retain the requisite legal

permits or otherwise to comply with Chinese legal requirements, we may be forced to obtain products from other manufacturers or to make other operational changes, including transferring our manufacturing to another manufacturer or to our own manufacturing facilities. Any such developments could have a material impact on our ability to meet our customers’ expectations and may materially impact our operating results. The United States has recently imposed tariffs on the import of certain products manufactured in China, and may propose further tariffs in the future, which could increase costs associated with the manufacturing of our products in China, and potentially other countries, and negatively impact our sales levels and profit margins.

In addition, for a variety of reasons, including changes in circumstances at our contract manufacturers or regarding our own business strategies, we may choose or be required to transfer the manufacturing of certain products to other manufacturing sites, including to our own manufacturing facilities. For example, we recently transitioned the manufacturing of our products with one of our contract manufacturers in China to our Shenzhen and Thailand manufacturing facilities and to other contract manufacturers. As a result of such transfers, our contract manufacturers may prioritize other customers or otherwise be unable to meet our demand. There also may be delays with the transfer of manufacturing equipment and successfully setting up that equipment at the transfer sites and training new operators. If such transfers are unsuccessful or take a longer period of time than expected, it could result in interruptions in supply and would likely impact our financial condition and results of operations.

Some of our purchase commitments with contract manufacturers are not cancellable which may impact our results of operations if customer forecasts driving these purchase commitments do not materialize and we are unable to sell the products to other customers. Alternatively, our contract manufacturers may not be able to meet our demand which would inhibit our ability to meet our customers’ demands and maintain or grow our revenues. Furthermore, it could be costly and require a long period of time to move products from one contract manufacturer to another which could result in interruptions in supply and adversely impact our financial condition and results of operations.

In addition, many of our products are sourced from suppliers based outside of the United States, primarily in Asia. Uncertainty with respect to our supplier’s abilities due to COVID-19 impacts, tax and trade policies, tariffs and government regulations affecting trade between the United States and other countries has recently increased. Major developments in tax policy or trade relations, such as the imposition of tariffs on imported products, could increase our product and product-related costs or require us to seek alternative suppliers, either of which could result in decreased sales or increased product and product-related costs.

If our customers do not qualify our manufacturing lines or the manufacturing lines of our subcontractors for volume shipments, our operating results could suffer.

Certain of our customers do not purchase products, other than limited numbers of evaluation units, prior to qualification of the manufacturing line for volume production. Our existing manufacturing lines, as well as each new manufacturing line, must pass through varying levels of qualification with certain of our customers. Some of our customers require that our manufacturing lines pass their specific qualification standards and that we, and any subcontractors that we may use, be registered under international quality standards. We may encounter quality control issues as a result of setting up new manufacturing lines in our facilities, relocating our manufacturing lines or introducing new products to fill production. We may be unable to obtain, or we may experience delays in obtaining, customer qualification of our manufacturing lines. If we introduce new contract manufacturing partners and move any production lines from existing internal or external facilities, the new production lines will likely need to be re-qualified with our customers. Any delays or failure to obtain qualifications would harm our operating results and customer relationships.

We depend on a limited number of suppliers for raw materials, packages and components, and any failure or delay by these suppliers in meeting our requirements could have an adverse effect on our business and results of operations.

We purchase raw materials, packages and components from a limited number of suppliers, who are often small and specialized. Additionally, some of our suppliers are our sole sources for certain materials, equipment and components. We depend on the timely and continued supply and quality of the materials, packages and components that our suppliers supply to us. We have not entered into long-term agreements with many of these suppliers. As a result, these suppliers may stop supplying us materials and equipment at any time. Our business and results of operations have been, and could continue to be, adversely affected by this dependency. Specific concerns we periodically encounter with our sole suppliers or limited number of suppliers include receipt of defective parts or contaminated materials, stoppages or delays of supply, insufficient resources to supply our requirements, substitution of more expensive or less reliable materials, increases in the price of supplies, and an inability to obtain reduced pricing from our suppliers in response to competitive pressures. Additionally, these suppliers may be unable to operate due to restrictions due to COVID-19 or any resulting economic impact to their business and ability to continue operations, and the supply of and costs of raw materials may be negatively impacted by the COVID-19 pandemic, trade protection policies such as tariffs, or escalating trade tensions, particularly with countries in Asia. Any disruption in the supply of the raw materials, packaging or components used in the manufacture and delivery of our products could have a material adverse impact on our business, financial condition and results of operations.

We contract with a number of large OEM and end-user service providers and product companies that have considerable bargaining power, which may require us to agree to terms and conditions that could have an adverse effect on our business or ability to recognize revenues.

Large OEM and end-user service providers and product companies comprise a significant portion of our customer base. These customers generally have greater purchasing power than smaller entities and, accordingly, often request and receive more favorable terms from suppliers, including us. As we seek to expand our sales to existing customers and acquire new customers, we may be required to agree to terms and conditions that are favorable to our customers and that may affect the timing of our ability to recognize revenue, increase our costs and have an adverse effect on our business, financial condition, and results of operations. Furthermore, large customers have increased buying power and ability to require onerous terms in our contracts with them, including pricing, warranties, and indemnification terms. If we are unable to satisfy the terms of these contracts, it could result in liabilities of a material nature, including litigation, damages, additional costs, loss of market share and loss of reputation. Additionally, the terms these large customers require, such as most-favored nation or exclusivity provisions, may impact our ability to do business with other customers and generate revenues from such customers.

Our products may contain defects that could cause us to incur significant costs, divert our attention from product development efforts and result in a loss of customers.

Our products are complex and defects may be found from time to time. Networking products in particular frequently contain undetected software or hardware defects when first introduced or as new versions are released. In addition, our products are often embedded in or deployed in conjunction with our customers’ products which incorporate a variety of components produced by third parties. As a result, when problems occur, it may be difficult to identify the source of the problem. These problems may cause us to incur significant damages or warranty and repair costs, divert the attention of our engineering personnel from our product development efforts and cause significant customer relation problems or loss of customers, all of which would harm our business.

We are subject to risks arising from our international operations, which may adversely affect our business, financial condition, and results of operations.

We derive a majority of our revenue from our international operations, and we plan to continue expanding our business in international markets in the future. In addition, we have extensive international manufacturing capabilities through third-party contract manufacturers, as well as through our own international facilities, with employees engaged in R&D, administration, manufacturing, support and sales and marketing activities.

As a result of our international operations, in addition to similar risks we face in our U.S. operations, we are affected by economic, business, regulatory, social, and political conditions in foreign countries, including the following:


•	impacts related to business disruptions and restrictions related to COVID-19;


•	changes in general IT spending;


•	the imposition of government controls, inclusive of critical infrastructure protection;

•

changes in or limitations imposed by trade protection laws or other regulatory orders or requirements in the United States or in other countries, including tariffs, sanctions, or other costs or requirements which may affect our ability to import or export our products from various countries or increase the cost to do so, including government action to restrict our ability to sell to foreign customers where sales of products may require export licenses (such as the U.S. Department of Commerce’s addition of Huawei to the Entity List in May 2019 and the prohibition of export and sale of certain products to ZTE Corporation in early 2018) and increased tariffs on various products that have been proposed by the U.S. government and other non-U.S. governments;


•	varying and potentially conflicting laws and regulations;


•	potential global or regional recession as a result of the COVID-19 pandemic and related responses of individuals, governments, private industry;


•	fluctuations in local economies;


•	wage inflation or a tightening of the labor market;


•	political developments of foreign nations, including Brexit and recent political developments in Hong Kong and the potential impact such developments or further actions could have on our customers in Hong Kong; and


•	the impact of the following on service provider and government spending patterns as well as our contract and internal manufacturing: political considerations, unfavorable changes in tax treaties or laws, unfavorable events that affect

foreign currencies, natural disasters, epidemic disease, labor unrest, earnings expatriation restrictions, misappropriation of intellectual property, military actions, acts of terrorism, political and social unrest and difficulties in staffing and managing international operations.

Moreover, local laws and customs in many countries differ significantly from or conflict with those in the United States or other countries in which we operate. In many foreign countries, particularly in those with developing economies, it is common for others to engage in business practices that are prohibited by our internal policies and procedures or U.S. regulations applicable to us. There can be no assurance that our employees, contractors, channel partners and agents will not take actions in violation of our policies and procedures, which are designed to ensure compliance with U.S. and foreign laws and policies. Violations of laws or key control policies by our employees, contractors, channel partners, or agents could result in termination of our relationships with customers and suppliers, financial reporting problems, fines and/or penalties for us, or prohibition on the importation or exportation of our products, and could have a material adverse effect on our business, financial condition and results of operations.

In addition to the above risks related to our international operations, we also face risks related to health epidemics, such as the COVID-19 pandemic. An outbreak of a contagious disease, and other adverse public health developments, particularly in Asia, could have a material and adverse effect on our business operations. The effects could include restrictions on our ability to travel to support our sites in Asia or our customers located there, disruptions in our ability to distribute products, and/or temporary closures of our facilities in Asia or the facilities of our suppliers or customers and their contract manufacturers. Disruption to the operations of our suppliers or customers and their contract manufacturers due to COVID-19 have impacted and will likely continue to impact our sales and operating results. For additional information regarding the impact of COVID-19 on our business, see the risk factor above titled “The effects of the COVID-19 pandemic has disrupted, and may continue to significantly disrupt our operations, including our ability to manufacture and supply products and perform research and development activities, which could have a material and adverse effect on our business, future revenues and financial condition. We are unable to predict the extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position and the achievement of our strategic objectives.”

Any or all of these factors could have a material adverse impact on our business, financial condition, and results of operations.

The threat of increasing tariffs, particularly to goods traded between the United States and China, could materially and adversely affect our business and results of operations.

Since the beginning of 2018, there has been increasing rhetoric, in some cases coupled with legislative or executive action, from several U.S. and foreign leaders regarding instituting tariffs against foreign imports of certain materials. More specifically, since 2018, the United States and China applied or proposed to apply tariffs to certain of each other’s exports, and we expect these actions to continue for the foreseeable future. The institution of trade tariffs both globally and between the United States and China specifically carries the risk of negatively impacting overall economic conditions, which could have negative repercussions on our industry and our business. Furthermore, imposition of tariffs or new or revised export, import or doing-business regulations, including trade sanctions, could cause a decrease in the sales of our products to customers located in China or other customers selling to Chinese end users, which would directly impact our business and results of operations.

We face a number of risks related to our strategic transactions.

We have in the past made several acquisitions, including our acquisition of Oclaro in December 2018. We may continue to expand and diversify our operations with additional acquisitions. We may be unable to identify or complete prospective acquisitions for many reasons, including increasing competition from other potential acquirers, the effects of consolidation in our industries and potentially high valuations of acquisition candidates. In addition, applicable antitrust laws and other regulations may limit our ability to acquire targets or force us to divest an acquired business. If we are unable to identify suitable targets or complete acquisitions, our growth prospects may suffer, and we may not be able to realize sufficient scale and technological advantages to compete effectively in all markets.

In connection with acquisitions, risks to us and our business include:


•	diversion of management’s attention from normal daily operations of the business;


•	unforeseen expenses, delays or conditions imposed upon the acquisition or transaction, including due to required regulatory approvals or consents;


•	unanticipated changes in the combined business due to potential divestitures or other requirements imposed by antitrust regulators;


•	unanticipated changes in the acquired business, including due to regulatory action or changes in the operating results or financial condition of the business;


•	the inability to retain and obtain required regulatory approvals, licenses and permits;


•	difficulties and costs in integrating the operations, technologies, products, IT and other systems, facilities and personnel of the purchased businesses;


•	loss of customers, suppliers or partners;


•	potential difficulties in completing projects associated with in-process R&D; and


•	an acquisition or strategic transaction may not further our business strategy as we expected or we may overpay for, or otherwise not realize the expected return on, our investments.

We have in the past, and may in the future, also divest or reduce our investment in certain businesses or product lines from time to time. For example, during the third quarter of fiscal year 2019, we announced the divestiture of our Datacom module business in Japan which was completed in the fourth quarter of fiscal year 2019, and in the second quarter of fiscal year 2020 we sold the assets associated with certain Lithium Niobate product lines manufactured by our San Donato site. Such divestitures involve risks, such as difficulty separating portions of or entire businesses, distracting employees, incurring potential loss of revenue, negatively impacting margins, and potentially disrupting customer relationships. We may also incur significant costs associated with exit or disposal activities, related impairment charges, or both.

If we are unable to successfully manage any of these risks in relation to any future acquisitions or divestitures, our business, financial condition and results of operations could be adversely impacted.

We may be unable to successfully implement our acquisitions strategy or integrate acquired companies and personnel with existing operations.

To the extent we are successful in making acquisitions, we may be unsuccessful in implementing our acquisitions strategy, or integrating acquired companies or product lines and personnel with existing operations, or the integration may be more difficult or more costly than anticipated. Some of the risks that may affect our ability to integrate or realize any anticipated benefits from acquired companies, businesses or assets include those associated with:


•	loss of customers, suppliers or partners;


•	potential difficulties in completing projects associated with in-process R&D;


•	an acquisition or strategic transaction may not further our business strategy as we expected or we may overpay for, or otherwise not realize the expected return on, our investments;


•	we may face unanticipated liabilities or our exposure for known contingencies and liabilities may exceed our estimates;


•	insufficient net revenue to offset increased expenses associated with acquisitions;


•	unexpected losses of key employees of the acquired company, or inability to maintain our company culture;


•	conforming the acquired company’s standards, processes, procedures and controls with our operations, including integrating Enterprise Resource Planning (“ERP”) systems and other key business applications;


•	coordinating new product and process development;


•	increasing complexity from combining operations;


•	increasing the scope, geographic diversity and complexity of our operations;


•	difficulties in consolidating facilities and transferring processes and know-how;


•	diversion of management’s attention from other business concerns;


•	dilution of our current stockholders as a result of any issuance of equity securities as acquisition consideration;


•	expenditure of cash that would otherwise be available to operate our business; and


•	incurrence of indebtedness on terms that are unfavorable to us, limit our operational flexibility or that we are unable to repay.

In addition, following an acquisition, we may have difficulty forecasting the financial results of the combined company and the market price of our common stock could be adversely affected if the effect of any acquisitions on our consolidated financial results is dilutive or is below the market's or financial analysts' expectations, or if there are unanticipated changes in the business or financial performance of the target company or the combined company. Any failure to successfully integrate acquired businesses may disrupt our business and adversely impact our business, financial condition and results of operations.

Changes in demand and customer requirements for our products may reduce manufacturing yields, which could negatively impact our profitability.

Manufacturing yields depend on a number of factors, including the volume of production due to customer demand and the nature and extent of changes in specifications required by customers for which we perform design-in work. Changes in manufacturing processes required as a result of changes in product specifications, changing customer needs, introduction of new product lines and changes in contract manufacturers may reduce manufacturing yields, resulting in low or negative margins on those products. Moreover, an increase in the rejection rate of products during the quality control process, before, during or after manufacture, results in lower gross margins from lower yields and additional rework costs. Any reduction in our manufacturing yields will adversely affect our gross margins and could have a material impact on our operating results.

We may not be able to realize tax savings from our international tax structure, which could materially and adversely affect our operating results.

We initiated a new international corporate structure more closely aligned with our international operations during the third quarter of fiscal 2018. The new corporate structure is intended to reduce our overall effective tax rate through changes among our wholly-owned subsidiaries in how we use our intellectual property, and how we structure our international procurement and sales operations. The new structure includes legal entities located in jurisdictions with income tax rates lower than the U.S. statutory tax rate. The intercompany arrangements are intended to result in income earned by such entities in accordance with arm’s-length principles and commensurate with functions performed, risks assumed and ownership of valuable corporate assets. We have not yet operationalized the new structure to the full extent possible due to various factors including the acquisition of Oclaro in the second quarter of fiscal 2019. We are currently in the process of assessing the Oclaro transaction’s impact to our tax structure and, depending on the outcome, we may make modifications to the new structure in order to achieve better tax and operational efficiency. If we are unable to fully adopt a new international structure, if substantial modifications to the new international structure or the way we operate our business are made in light of the Oclaro acquisition or for other reasons, if changes in domestic and international tax laws negatively impact the structure, if we do not operate our business consistent with the new structure and applicable tax provisions, if we fail to achieve our revenue and profit goals, or if it is successfully challenged by the U.S. or foreign tax authorities, we may be unable to realize the anticipated tax savings which could materially and adversely affect our operating and financial results.

We have agreed to reimburse Viavi for certain tax liabilities and related costs that may be incurred by Viavi, under certain circumstances, as a result of implementing the new corporate structure or a modified structure in the future. In addition, the implementation of such a structure has required us to incur expenses, and may require that we incur additional expenses, for which we may not realize the anticipated benefit or it may take us several years to fully realize the anticipated benefit.

Changes in tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.

As a multinational corporation, we are subject to income taxes as well as non-income based taxes, in both the U.S. and various foreign jurisdictions. Significant uncertainties exist with respect to the amount of our tax liabilities, including those arising from potential changes in laws in the countries in which we do business and the possibility of adverse determinations with respect to the application of existing laws. Many judgments are required in determining our worldwide provision for income taxes and other tax liabilities, and we are under audit by various tax authorities, which often do not agree with positions taken by us on our tax returns. Any unfavorable resolution of these uncertainties may have a significant adverse impact on our tax rate.

Increasingly, countries around the world are actively considering or have enacted changes in relevant tax, accounting and other laws, regulations and interpretations. In particular, the Tax Cuts and Jobs Act (the “Tax Act”) contains many significant changes to the U.S. tax laws that affected our fiscal quarter ended March 28, 2020, and which will continue to affect our fiscal years thereafter. Information regarding the Tax Act and the impact of the Tax Act on our tax profile is included in our Annual Report on Form 10-K for our fiscal year ended June 29, 2019.

The reduction in the U.S. federal statutory rate is expected to positively impact our federal cash tax liability. However, the ultimate impact is subject to the effect of other complex provisions in the Tax Act (including the BEAT and GILTI), and it is possible that any impact of BEAT, GILTI, or other provisions of the Tax Act could significantly reduce, or outweigh, the benefit of the reduction in the U.S. federal statutory rate. The U.S. Treasury Department and the Internal Revenue Service (IRS), and other

standards-setting bodies may issue guidance on how the provisions of the Tax Act will be applied that is different from our interpretation. The Tax Act requires complex computations not previously required or produced, and significant judgments and assumptions in the interpretation of the law were made in producing our provisional estimates. We also anticipate that uncertainty in the application of the Tax Act to our ongoing operations as well as possible adverse future law changes attributable to changes in the U.S. political environment could have an adverse impact on our future tax rate. Other countries also continue to enact and consider enacting new laws, which could adversely affect us. The foregoing items could increase our future tax expense, could change our future intentions regarding reinvestment of foreign earnings, and could have a material adverse effect on our business, financial condition and results of operations.

The income and non-income tax regimes we are subject to or operate under are unsettled and may be subject to significant change. Changes in tax laws or tax rulings, or changes in interpretations of existing laws, could materially affect our financial position and results of operations. Many countries in Europe, as well as a number of other countries and organizations, have recently proposed or recommended changes to existing tax laws or have enacted new laws that could increase our tax obligations where we do business or require us to change the manner in which we operate our business. The Organization for Economic Cooperation and Development has been working on a set of internationally accepted tax rules as a part of a Base Erosion and Profit Sharing (BEPS) Project aimed at tax avoidance, and that the roll-out of BEPS action steps by various jurisdictions may change aspects of the existing framework under which our tax obligations are determined in many of the countries in which we do business.

On June 7, 2019, the Ninth Circuit Court of Appeals, reversing a previous decision of the U.S. Tax Court, held that the U.S. Treasury Department’s regulations requiring the inclusion of stock-based compensation expense in a taxpayer’s cost-sharing calculations were valid. On November 12, 2019, the U.S. Court of Appeals for the Ninth Circuit denied the en banc rehearing request filed by the taxpayer on July 22, 2019. We have a research and development cost sharing arrangement with one of our foreign affiliates. Our financial statements have been prepared consistent with the ruling and we will continue to monitor any ongoing developments, including a potential appeal to the U.S. Supreme Court, to determine if future changes are required.

Our subsidiary in Thailand currently operates under a tax holiday which will expire in fiscal 2025 unless extension is granted by the Thailand government and we continue to meet the requirements thereunder. If we do not meet the tax holiday requirements, if we are not granted an extension by the Thailand government, or if we decide not to apply for an extension of the tax holiday, income earned in Thailand will be subject to a higher statutory income tax rate, which may cause our effective tax rate to increase and reduce our liquidity and cash flow.

Our operating results may be subject to volatility due to fluctuations in foreign currency.

We are exposed to foreign exchange risks with regard to our international operations which may affect our operating results. Since we conduct business in currencies other than U.S. dollars but report our financial results in U.S. dollars, we face exposure to fluctuations in currency exchange rates. Although we price our products primarily in U.S. dollars, a portion of our operating expenses are incurred in foreign currencies. For example, a portion of our expenses are denominated in U.K. pound sterling, Chinese yuan and Thai baht. Fluctuations in the exchange rate between these currencies and other currencies in which we collect revenues and/or pay expenses could have a material effect on our future operating results. If the value of the U.S. dollar depreciates relative to certain other foreign currencies, it would increase our costs as expressed in U.S. dollars. Conversely, if the U.S. dollar strengthens relative to other currencies, such strengthening could raise the relative cost of our products to non-U.S. customers, especially as compared to foreign competitors, and could reduce demand.

Our ability to develop, market, and sell products could be harmed if we are unable to retain or hire key personnel.

Our future success depends upon our ability to recruit and retain the services of executive, engineering, sales and marketing, and support personnel. The supply of highly qualified individuals, in particular engineers in very specialized technical areas, or sales people specializing in the service provider, enterprise and commercial laser markets, is limited and competition for such individuals is intense. None of our officers or key employees is bound by an employment agreement for any specific term. The loss of the services of any of our key employees, the inability to attract or retain personnel in the future or delays in hiring required personnel and the complexity and time involved in replacing or training new employees, could delay the development and introduction of new products, and negatively impact our ability to market, sell, or support our products.

We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.

We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including supporting the development and introduction of new products, addressing new markets, engaging in strategic transactions and partnerships, improving or expanding our operating infrastructure or acquiring complementary businesses and technologies. In March 2017, we issued and sold a total of $450 million in aggregate principal amount of 2024 Notes, and in December 2019, we issued and sold a total of $1,050 million in aggregate principal amount of 2026 Notes. We may

in the future engage in additional equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity, equity-linked or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be harmed.

Our ability to hire and retain employees may be negatively impacted by changes in immigration laws, regulations and procedures.

Foreign nationals who are not U.S. citizens or permanent residents constitute an important part of our U.S. workforce, particularly in the areas of engineering and product development. Our ability to hire and retain these workers and their ability to remain and work in the United States are impacted by laws and regulations, as well as by procedures and enforcement practices of various government agencies. Changes in immigration laws, regulations or procedures, including those that may be enacted by the current U.S. presidential administration and in the United Kingdom or the European Union in connection with Brexit, may adversely affect our ability to hire or retain such workers, increase our operating expenses and negatively impact our ability to deliver our products and services.

Any failure, disruption or security breach of our information technology infrastructure or information management systems could have an adverse impact on our business and operations.

Our business depends significantly on effective and efficient information management systems, and the reliability and security of our information technology infrastructure are essential to the health and expansion of our business. For example, the information gathered and processed by our information management systems assists us in managing our supply chain, monitoring customer accounts, and protecting our proprietary and confidential business information, plans, trade secrets, and intellectual property, among other things. In addition, these systems may also contain personal data or other protected information about our employees, our customers’ employees, or others. We must continue to expand and update this infrastructure in response to our changing requirements as well as evolving security standards and risks.

In some cases, we may rely upon third-party providers of hosting, support and other services to meet our information technology requirements. Any failure to manage, expand and update our information technology infrastructure, including our ERP system and other applications, any failure in the extension implementation or operation of this infrastructure, or any failure by our hosting and support partners or other third-party service providers in the performance of their services could materially harm our business. In addition, we have partnered with third parties to support our information technology systems and to help design, build, test, implement and maintain our information management systems. Our merger, acquisition and divestiture activity, including our acquisition of Oclaro in December 2018, will also require transitions to or from, and the integration of, various information management systems within our overall enterprise architecture, including our ERP system and other applications. Those systems that we acquire may also pose security risks of which we are unaware or unable to mitigate, particularly during the transition of these systems.

Like other companies, we are subject to ongoing attempts by malicious actors, including through hacking, malware, ransomware, denial-of-service attacks, social engineering, exploitation of internet-connected devices, and other attacks, to obtain unauthorized access or acquisition of confidential information or otherwise affect service reliability and threaten the confidentiality, integrity and availability of information on our systems. We have been in the past, and may be in the future, subject to social engineering and other cybersecurity attacks, and these attacks may become more prevalent while our workforce is distributed following shelter-in-place orders. Further, our third party service providers may have been and may be in the future subject to such attacks. In addition, actions by our employees, service providers, partners, contractors or others, whether malicious or in error, could affect the security of our systems. Further, a breach of our information technology infrastructure could result in the misappropriation of intellectual property, business plans or trade secrets. Any failure of our systems or those of our third-party service providers could result in unauthorized access or acquisition of such proprietary information, and any actual or perceived security breach could cause significant damage to our reputation and adversely impact our relationships with our customers. Additionally, while our security systems are designed to maintain the physical security of our facilities and information systems, accidental or willful security breaches or other unauthorized access by third parties to our facilities or our information systems could lead to misappropriation of proprietary and confidential information.

Despite our implementation of security measures, our systems and those of our third-party service providers are vulnerable to damage from these types of attacks or errors. In addition, our systems may be impacted by natural disasters, terrorism or other similar disruptions. Any system failure, accident or security breach affecting us or our third-party providers could result in

disruptions to our operations and loss of, or unauthorized access or damage to, our data or in inappropriate disclosure of confidential information. Any actual or alleged disruption to, or security breach affecting, our systems or those of our third-party partners could cause significant damage to our reputation, lead to theft of our protected intellectual property and trade secrets, result in legal obligations or liability, affect our relationships with our customers, and ultimately harm our business. In addition, we may be required to incur significant costs to protect against or mitigate damage caused by these disruptions or security breaches in the future.

Our revenues, operating results, and cash flows may fluctuate from period to period due to a number of factors, including unfavorable economic and market conditions, which makes predicting financial results difficult.

Spending on optical communication and laser products is subject to cyclical and uneven fluctuations, which could cause our financial results to fluctuate unevenly and unpredictably. It can be difficult to predict the degree to which end-customer demand and the seasonality and uneven sales patterns of our OEM partners or other customers will affect our business in the future, particularly as we or they release new or enhanced products. While our fourth fiscal quarters are typically strongest, future buying patterns may differ from historical seasonality. Further, if the mix of revenue changes, it may also cause results to differ from historical seasonality. Accordingly, our quarterly and annual revenues, operating results, cash flows, and other financial and operating metrics may vary significantly in the future, and the results of any prior periods should not be relied upon as an indication of future performance.

Adverse changes to and uncertainty in the global economy, particularly in light of the impacts of COVID-19 and a potential global recession resulting therefrom, may lead to decreased demand for our products and revenue fluctuations, increased price competition for our products, and may increase the risk of excess and obsolete inventories and higher overhead costs as a percentage of revenue. Declines or uncertainty in particular geographic regions, such as China or Europe, may impact IT-related spending generally and consequently, may lead to lower growth or a decline in our markets. The loss or delay of orders from any of our significant customers could cause our revenue and profitability to suffer. The impact of economic challenges on the global financial markets could further negatively impact our operations by affecting the solvency of our customers, the solvency of our key suppliers or the ability of our customers to obtain credit to finance purchases of our products. If economic conditions deteriorate or remain uncertain, our financial condition and results of operations would likely be materially and adversely impacted.

If we have insufficient proprietary rights or if we fail to protect our rights, our business would be materially harmed.

We seek to protect our products and product roadmaps in part by developing and/or securing proprietary rights relating to those products, including patents, trade secrets, know-how and continuing technological innovation. The steps we take to protect our intellectual property may not adequately prevent misappropriation or ensure that others will not develop competitive technologies or products. Other companies may be investigating or developing technologies that are similar to our own. It is possible that patents may not be issued from any of our pending applications or those we may file in the future and, if patents are issued, the claims allowed may not be sufficiently broad to deter or prohibit others from making, using or selling products that are similar to ours, or such patents could be invalidated or ruled unenforceable. We do not own patents in every country in which we sell or distribute our products, and thus others may be able to offer identical products in countries where we do not have intellectual property protections. In addition, the laws of some territories in which our products are or may be developed, manufactured or sold, including Europe, Asia-Pacific or Latin America, may not protect our products and intellectual property rights to the same extent as the laws of the United States. Any patents issued to us may be challenged, invalidated or circumvented. Additionally, we are currently a licensee for a number of third-party technologies including software and intellectual property rights from academic institutions, our competitors and others, and we are required to pay royalties to these licensors for the use thereof. In the future, if such licenses are unavailable or if we are unable to obtain such licenses on commercially reasonable terms, we may not be able to rely on such third-party technologies which could inhibit our development of new products, impede the sale of some of our current products, substantially increase the cost to provide these products to our customers, and could have a significant adverse impact on our operating results.

We also seek to protect our important trademarks by endeavoring to register them in certain countries. We have not registered our trademarks in every country in which we sell or distribute our products, and thus others may be able to use the same or confusingly similar marks in countries where we do not have trademark registrations. We have adopted Lumentum as a house trademark and trade name for our company, and are in the process of establishing rights in this name and brand. We have also adopted the Lumentum logo as a house trademark for our company, and are in the process of establishing rights in this brand. Trademarks associated with the Lumentum brand have been registered in the United States or other jurisdictions, however, the efforts we take to maintain registration and protect trademarks, including the Lumentum brand, may not be sufficient or effective. Although we have registered marks associated with the Lumentum brand, third parties may seek to oppose or otherwise challenge these registrations. There is the possibility that, despite efforts, the scope of the protection obtained for our trademarks, including the Lumentum brand, will be insufficient or that a registration may be deemed invalid or unenforceable in one or more jurisdictions throughout the world.

Further, a breach of our information technology infrastructure could result in the misappropriation of intellectual property, business plans or trade secrets. Any failure of our systems or those of our third-party service providers could result in unauthorized access or acquisition of such proprietary information, and any actual or perceived security breach could cause significant damage to our reputation and adversely impact our relationships with our customers.

Our products may be subject to claims that they infringe the intellectual property rights of others, the resolution of which may be time-consuming and expensive, as well as require a significant amount of resources to prosecute, defend, or make our products non-infringing.

Lawsuits and allegations of patent infringement and violation of other intellectual property rights occur regularly in our industry. We have in the past received, and anticipate that we will receive in the future, notices from third parties claiming that our products infringe upon their proprietary rights, with two distinct sources of such claims becoming increasingly prevalent. First, large technology companies, including some of our customers and competitors, are seeking to monetize their patent portfolios and have developed large internal organizations that may approach us with demands to enter into license agreements. Second, patent-holding companies that do not make or sell products (often referred to as “patent trolls”) may claim that our products infringe upon their proprietary rights. We respond to these claims in the course of our business operations. The litigation or settlement of these matters, regardless of the merit of the claims, could result in significant expense and divert the efforts of our technical and management personnel, regardless of whether or not we are successful. If we are unsuccessful, we could be required to expend significant resources to develop non-infringing technology or to obtain licenses to the technology that is the subject of the litigation. We may not be successful in such development, or such licenses may not be available on commercially reasonable terms, or at all. Without such a license, or if we are the subject of an exclusionary order, our ability to make our products could be limited and we could be enjoined from future sales of the infringing product or products, which could adversely affect our revenues and operating results. Additionally, we often indemnify our customers against claims of infringement related to our products and may incur significant expenses to defend against such claims. If we are unsuccessful defending against such claims, we may be required to indemnify our customers against any damages awarded.

We also face risks that third parties may assert trademark infringement claims against us in one or more jurisdictions throughout the world related to our Lumentum and Oclaro brands and/or other trademarks. The litigation or settlement of these matters, regardless of the merit of the claims, could result in significant expense and divert the efforts of our technical and management personnel, regardless of whether or not we are successful. If we are unsuccessful, trademark infringement claims against us could result in significant monetary liability or prevent us from selling some or all of our products or services under the challenged trademark. In addition, resolution of claims may require us to alter our products, labels or packaging, license rights from third parties, or cease using the challenged trademark altogether, which could adversely affect our revenues and operating results.

We face certain litigation risks that could harm our business.

We are now, and in the future we may become, subject to various legal proceedings and claims that arise in or outside the ordinary course of business. The results of legal proceedings are difficult to predict. Moreover, many of the complaints filed against us may not specify the amount of damages that plaintiffs seek, and we therefore may be unable to estimate the possible range of damages that might be incurred should these lawsuits be resolved against us. While we may be unable to estimate the potential damages arising from such lawsuits, certain of them assert types of claims that, if resolved against us, could give rise to substantial damages. Thus, an unfavorable outcome or settlement of one or more of these lawsuits could have a material adverse effect on our financial condition, liquidity and results of operations. Even if these lawsuits are not resolved against us, the uncertainty and expense associated with unresolved lawsuits could seriously harm our business, financial condition and reputation. Litigation is generally costly, time-consuming and disruptive to normal business operations. The costs of defending these lawsuits have been significant in the past, will continue to be costly and may not be covered by our insurance policies. The defense of these lawsuits could also result in continued diversion of our management’s time and attention away from business operations, which could harm our business. For additional discussion regarding litigation, see “Part II, Item 1. Legal Proceedings.”

Our products incorporate and rely upon licensed third-party technology, and if licenses of third-party technology do not continue to be available to us or are not available on terms acceptable to us, our revenues and ability to develop and introduce new products could be adversely affected.

We integrate licensed third-party technology into certain of our products. From time to time, we may be required to license additional technology from third-parties to develop new products or product enhancements. Third-party licenses may not be available or continue to be available to us on commercially reasonable terms. The failure to comply with the terms of any license, including free open source software, may result in our inability to continue to use such license. Our inability to maintain or re-license any third-party licenses required in our products or our inability to obtain third-party licenses necessary to develop new products and product enhancements, could potentially require us to develop substitute technology or obtain substitute technology of lower quality or performance standards or at a greater cost, any of which could delay or prevent product shipment and harm our business, financial condition, and results of operations.

We are subject to laws and other regulations worldwide including with respect to environmental matters, securities laws, privacy and data protection, compliance with which could increase our expenses and harm our operating results.

Our operations and our products are subject to various federal, state and foreign laws and regulations, including those governing pollution and protection of human health and the environment in the jurisdictions in which we operate or sell our products. These laws and regulations govern, among other things, wastewater discharges and the handling and disposal of hazardous materials in our products. Our failure to comply with current and future environmental or health or safety requirements could cause us to incur substantial costs, including significant capital expenditures, to comply with such environmental laws and regulations and to clean up contaminated properties that we own or operate. Such clean-up or compliance obligations could result in disruptions to our operations. Additionally, if we are found to be in violation of these laws, we could be subject to governmental fines or civil liability for damages resulting from such violations. These costs could have a material adverse impact on our financial condition or operating results.

From time to time new regulations are enacted, and it is difficult to anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These regulations include, for example, the Registration, Evaluation, Authorization and Restriction of Chemicals (“REACH”), the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (“RoHS”) and the Waste Electrical and Electronic Equipment Directive (“WEEE”) enacted in the European Union which regulate the use of certain hazardous substances in, and require the collection, reuse and recycling of waste from, certain products we manufacture. These regulations and similar legislation may require us to re-design our products to ensure compliance with the applicable standards, for example by requiring the use of different types of materials, which could have an adverse impact on the performance of our products, add greater testing lead-times for product introductions or other similar effects. We believe we comply with all such legislation where our products are sold and we continuously monitor these laws and the regulations being adopted under them to determine our responsibilities.

In addition, pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, the SEC has promulgated rules requiring disclosure regarding the use of certain “conflict minerals” that are mined from the Democratic Republic of Congo and adjoining countries and procedures regarding a manufacturer’s efforts to prevent the sourcing of such minerals. Complying with these disclosure requirements involves substantial diligence efforts to determine the source of any conflict minerals used in our products and may require third-party auditing of our diligence process. These efforts may demand internal resources that would otherwise be directed towards operations activities.

Since our supply chain is complex, we may face reputational challenges if we are unable to sufficiently verify the origins of the conflict minerals used in our products. Additionally, if we are unable to satisfy those customers who require that all of the components of our products are determined to be conflict free, they may choose a competitor’s products which could materially impact our financial condition and operating results.

We are also subject to laws and regulations with respect to personal data we collect from our employees, customers, and others. These laws and regulations are subject to frequent modifications and updates and require ongoing supervision. For example, the European Union adopted a General Data Protection Regulation (“GDPR”) that became effective in May 2018, and has established new, and in some cases more stringent, requirements for data protection in Europe, and which provides for substantial penalties for noncompliance. We have made certain modifications to our practices in order to comply with these or other requirements, and may be required to make additional modifications in order to comply with these or other requirements relating to privacy and data protection in the future, each of which may require us to incur significant costs and expenses. Additionally, California enacted legislation in June 2018, the California Consumer Privacy Act (“CCPA”), which went into effect on January 1, 2020 and which, among other things, requires covered companies to provide new disclosures to California consumers. Similar legislation has been proposed or adopted in other states. Aspects of the CCPA and these other state laws and regulations, as well as their enforcement, remain unclear. The effects of the CCPA and these other state laws and regulations are potentially significant, however, and may require us to modify our data processing practices and policies and to incur substantial costs and expenses in an effort to comply. Laws and regulations relating to privacy and data protection continue to evolve in various jurisdictions, with existing laws and regulations subject to new and differing interpretations and new laws and regulations being proposed and adopted. It is possible that our practices may be deemed not to comply with those privacy and data protection legal requirements that apply to us now or in the future.

Further, in June 2016, a referendum was passed in the United Kingdom to leave the European Union, commonly referred to as “Brexit.” The United Kingdom officially left the European Union on January 31, 2020, with a transitional period set to end on December 31, 2020. Brexit created an uncertain political and economic environment in the United Kingdom and other European Union countries. For example, while the United Kingdom has enacted a Data Protection Bill that substantially implements GDPR, which became law in May 2018 and was the subject of statutory amendments in 2019 that further aligned it with the GDPR, there remains uncertainty with regard to how data transfers between the United Kingdom and the European Union will be regulated following Brexit.

Our failure or perceived failure to comply with any of the foregoing legal and regulatory requirements could result in increased costs for our products, monetary penalties, damage to our reputation, government inquiries and investigations, and legal action. Furthermore, the legal and regulatory requirements that are applicable to our business are subject to change from time to time, which increases our monitoring and compliance costs and the risk that we may fall out of compliance. Additionally, we may be required to ensure that our suppliers comply with applicable laws and regulations. If we or our suppliers fail to comply with such laws or regulations, we could face sanctions for such noncompliance, and our customers may refuse to purchase our products, which would have a material adverse effect on our business, financial condition and results of operations.

Our sales may decline if we are unable to obtain government authorization to export certain of our products, and we may be subject to legal and regulatory consequences if we do not comply with applicable export control laws and regulations.

Exports of certain of our products are subject to export controls imposed by the U.S. government and administered by the U.S. Departments of State and Commerce. In certain instances, these regulations may require pre-shipment authorization from the administering department. For products subject to the Export Administration Regulations (“EAR”) administered by the Department of Commerce’s Bureau of Industry and Security, the requirement for a license is dependent on the type and end use of the product, the final destination, the identity of the end user and whether a license exception might apply. Virtually all exports of products subject to the International Traffic in Arms Regulations (“ITAR”) administered by the Department of State’s Directorate of Defense Trade Controls, require a license. Certain of our fiber optics products are subject to EAR and certain of our RF-over-fiber products, as well as certain products and technical data, are developed with government funding, and are currently subject to ITAR. Products and the associated technical data developed and manufactured in our foreign locations are subject to export controls of the applicable foreign nation.

Given the current global political climate, obtaining export licenses can be difficult and time-consuming. Failure to obtain export licenses for these shipments could significantly reduce our revenue and materially adversely affect our business, financial condition and results of operations. Compliance with U.S. government regulations also subjects us to additional fees and costs. The absence of comparable restrictions on competitors in other countries may adversely affect our competitive position.

Further, there is increased attention from the government and the media regarding potential threats to U.S. national security and foreign policy relating to certain foreign entities, particularly Chinese entities, and the imposition of enhanced restrictions or sanctions regarding the export of our products or on specific foreign entities that would restrict their ability to do business with U.S. companies may materially adversely affect our business. For example, on May 16, 2019, Huawei was added to the Entity List of the Bureau of Industry and Security of the U.S. Department of Commerce, which imposes limitations on the supply of certain U.S. items and product support to Huawei. We cannot predict what additional actions the U.S. government may take with respect to Huawei or other of our customers, including modifications to or interpretations of Entity List restrictions, export restrictions, tariffs, or other trade limitations or barriers.

Our association with customers that are or become subject to U.S. regulatory scrutiny or export restrictions could negatively impact our business. Governmental actions such as these could subject us to actual or perceived reputational harm among current or prospective investors, suppliers or customers, customers of our customers, other parties doing business with us, or the general public. Any such reputational harm could result in the loss of investors, suppliers or customers, which could harm our business, financial condition, operating results or prospects.

In addition, certain of our significant customers and suppliers have products that are subject to U.S. export controls, and therefore these customers and suppliers may also be subject to legal and regulatory consequences if they do not comply with applicable export control laws and regulations. Such regulatory consequences could disrupt our ability to obtain components from our suppliers, or to sell our products to major customers, which could significantly increase our costs, reduce our revenue and materially adversely affect our business, financial condition and results of operations.

If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, and Nasdaq listing requirements. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight.

Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation or improvement, could cause us to delay reporting of our financial results, be subject to one or more investigations or enforcement actions by state or federal regulatory agencies, stockholder lawsuits or other adverse actions requiring us to incur defense costs, pay fines, settlements

or judgments. Any such failures could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the NASDAQ stock market.

We face a number of risks related to our Separation from Viavi, including those associated with ongoing indemnification obligations and tax and accounting-related risks, which could adversely affect our business, financial condition, results of operations and cash flows.

In August 2015, we became an independent publicly-traded company through the distribution by JDS Uniphase Corporation (“JDSU”) to its stockholders of 80.1% of our outstanding common stock (the “Separation”). The Separation and Distribution Agreement dated as of July 31, 2015 by and among JDSU, Lumentum Holdings Inc. and Lumentum Operations LLC (the “Separation Agreement”) requires that we indemnify Viavi, and that Viavi indemnify us, for certain specified liabilities related to the Separation. Among other things, we are obligated to indemnify Viavi against certain tax-related liabilities that may result from the breach of any of our representations or covenants made in connection with the Separation. Our indemnification obligations are not subject to maximum loss clauses and, if we are required to indemnify Viavi under the circumstances set forth in the Separation Agreement, we may be subject to substantial liabilities. Furthermore, third parties could seek to hold us responsible for any of the liabilities that Viavi has agreed to indemnify us for, and there can be no assurance that the indemnity from Viavi will be sufficient to protect us against the full amount of such liabilities, or that Viavi will be able to fully satisfy its indemnification obligations.

Risks Related to Our Common Stock

Our stock price may be volatile and may decline regardless of our operating performance.

Our common stock is listed on the Nasdaq Global Select Market (“NASDAQ”) under the symbol “LITE”. Since shares of our common stock commenced trading on the NASDAQ stock market in August 2015, the reported high and low closing prices of our common stock per NASDAQ has ranged from $14.12 to $92.85, through March 28, 2020. The market price of our common stock may fluctuate significantly due to a number of factors, some of which may be beyond our control, including:


•	general economic and market conditions and other external factors, particularly in light of the market volatility driven by the impact of COVID-19;


•	actual or anticipated fluctuations in our quarterly or annual operating results;


•	changes in earnings estimates by securities analysts or our ability to meet those estimates;


•	the operating and stock price performance of other comparable companies;


•	a shift in our investor base;


•	the financial performance of other companies in our industry, and of our customers;


•	success or failure of our business strategy;


•	credit market fluctuations which could negatively impact our ability to obtain financing as needed;


•	changes to the regulatory and legal environment in which we operate;


•	announcements by us, competitors, customers, or our contract manufacturers of significant acquisitions or dispositions;


•	investor perception of us and our industry;


•	changes in accounting standards, policies, guidance, interpretations or principles;


•	litigation or disputes in which we may become involved;


•	overall market fluctuations;


•	sales of our shares by our officers, directors, or significant stockholders; and


•	the timing and amount of dividends and share repurchases, if any.

In addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many technology companies. Stock prices of many technology companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have instituted securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business and adversely affect our business, results of operations, financial condition and cash flows.

Servicing our 2024 Notes and 2026 Notes may require a significant amount of cash, and we may not have sufficient cash flow or the ability to raise the funds necessary to satisfy our obligations under the 2024 Notes or 2026 Notes, and our current and future indebtedness may limit our operating flexibility or otherwise affect our business.

Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the 2024 Notes and 2026 Notes, or to make cash payments in connection with any conversion of the 2024 Notes, 2026 Notes or upon any fundamental change if holders of the applicable series of notes require us to repurchase their notes for cash, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not generate cash flow from operations in the future sufficient to service our indebtedness and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring indebtedness or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations. In addition, our existing and future indebtedness could have important consequences to our stockholders and significant effects on our business. For example, it could:


•	make it more difficult for us to satisfy our debt obligations, including the 2024 Notes and the 2026 Notes;


•	increase our vulnerability to general adverse economic and industry conditions;


•	require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital and other general corporate purposes;


•	limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;


•	restrict us from exploiting business opportunities;


•	place us at a competitive disadvantage compared to our competitors that have less indebtedness; and


•	limit our availability to borrow additional funds for working capital, capital expenditures, acquisitions, debt service requirements, execution of our business strategy or other general purposes.

Transactions relating to our 2024 Notes and 2026 Notes may dilute the ownership interest of existing stockholders, or may otherwise depress the price of our common stock.

If the 2024 Notes or the 2026 Notes are converted by holders of such series, we have the ability under the applicable indenture to deliver cash, equity, common stock, or any combination of cash or common stock, at our election upon conversion of the applicable series of convertible notes. If we elect to deliver common stock upon conversion of the 2024 Notes or the 2026 Notes, it would dilute the ownership interests of existing stockholders. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, certain holders of the 2024 Notes or the 2026 Notes may engage in short selling to hedge their position in the convertible notes. Anticipated future conversions of the 2024 Notes or 2026 Notes into shares of our common stock could depress the price of our common stock.

We do not expect to pay dividends on our common stock.

We do not currently expect to pay dividends on our common stock. The payment of any dividends to our stockholders in the future, and the timing and amount thereof, if any, is within the discretion of our board of directors. Our board of directors’ decisions regarding the payment of dividends will depend on many factors, such as our financial condition, earnings, capital requirements, potential debt service obligations or restrictive covenants, industry practice, legal requirements, regulatory constraints and other factors that our board of directors deems relevant.

In addition, because we are a holding company with no material direct operations, we are dependent on loans, dividends and other payments from our operating subsidiaries to generate the funds necessary to pay dividends on our common stock. However, our operating subsidiaries’ ability to make such distributions will be subject to their operating results, cash requirements and financial condition and the applicable provisions of Delaware law that may limit the amount of funds available for distribution.

Our ability to pay cash dividends may also be subject to covenants and financial ratios related to existing or future indebtedness, and other agreements with third parties.

Certain provisions in our charter and Delaware corporate law could hinder a takeover attempt.

We are subject to the provisions of Section 203 of the DGCL which prohibits us, under some circumstances, from engaging in business combinations with some stockholders for a specified period of time without the approval of the holders of substantially all of our outstanding voting stock. Such provisions could delay or impede the removal of incumbent directors and could make more difficult a merger, tender offer or proxy contest involving us, even if such events could be beneficial, in the short-term, to the interests of our stockholders. In addition, such provisions could limit the price that some investors might be willing to pay in the future for shares of our common stock. Our certificate of incorporation and bylaws contain provisions providing for the limitations of liability and indemnification of our directors and officers, allowing vacancies on our board of directors to be filled by the vote of a majority of the remaining directors, granting our board of directors the authority to establish additional series of preferred stock and to designate the rights, preferences and privileges of such shares (commonly known as “blank check preferred”) and providing that our stockholders can take action only at a duly called annual or special meeting of stockholders, which may only be called by the chairman of the board of directors, the chief executive officer or the board of directors. These provisions may also have the effect of deterring hostile takeovers or delaying changes in control or changes in our management.

Our bylaws designate Delaware courts as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could discourage lawsuits against us or our directors and officers.

Our bylaws provide that, unless we consent in writing to an alternative forum, the state or federal courts of Delaware are the sole and exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting breach of fiduciary duty, or other wrongdoing, by our directors, officers or other employees to us or our stockholders; any action asserting a claim against Lumentum pursuant to the Delaware General Corporation Law or our certificate of incorporation or bylaws; any action asserting a claim against Lumentum governed by the internal affairs doctrine; or any action to interpret, apply, enforce or determine the validity of our certificate of incorporation or bylaws. This exclusive forum provision may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors or officers, which may discourage such lawsuits against us or our directors and officers.

Alternatively, if a court outside of Delaware were to find this exclusive forum provision inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings described above, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial condition or results of operations.

Item 6. Exhibits

The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the Securities and Exchange Commission.



		Incorporated by Reference			Filed
Exhibit No.	Exhibit Description	Form	Exhibit	Filing Date	Herewith
31.1	Certification of the Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
31.2	Certification of the Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1†	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
32.2†	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
101	The following financial information from Lumentum Holdings Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2020 formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months and nine months ended March 28, 2020 and March 30, 2019; (ii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months and nine months ended March 28, 2020 and March 30, 2019; (iii) Condensed Consolidated Balance Sheets as of March 28, 2020 and June 29, 2019; (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended March 28, 2020 and March 30, 2019; (v) Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity for the three months and nine months ended March 28, 2020 and March 30, 2019; and (vi) Notes to the Consolidated Financial Statements.				X
104	Cover Page Interactive Data File, formatted in Inline XBRL (included in Exhibit 101).				X

† The certifications furnished in Exhibits 32.1 and 32.2 that accompany this report are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this report, irrespective of any general incorporation language contained in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		LUMENTUM HOLDINGS INC.

Date:	May 5, 2020	By: /s/ Wajid Ali
		By: Wajid Ali
		Executive Vice President, Chief Financial Officer